STOWERS INSTITUTE FOR MEDICAL RESEARCH: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- STOWERS INSTITUTE FOR MEDICAL RESEARCH (EIN 20-2993509)
- Tax period
- 2019-01-01 to 2019-12-31
- Filed
- 2020-08-17
- IRS object ID
- 202002309349303250
- Schema version
- 2019v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2020-08-17T14:54:48-05:00 | ReturnTs |
| Tax Period End | 2019-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PRICEWATERHOUSECOPPERS LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 600 13TH ST NW STE 1000 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20005 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 202993509 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | STOWERS INSTITUTE FOR MEDICAL RESEARCH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % KATY GRAHAM | InCareOfNm |
| Business Name Control | STOW | BusinessNameControlTxt |
| Phone | 8169264000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1000 EAST 50TH STREET | AddressLine1Txt |
| City | KANSAS CITY | CityNm |
| State Abbreviation | MO | StateAbbreviationCd |
| ZIP | 64110 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | DAVID M CHAO | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 8169264000 | PhoneNum |
| Signature | 2020-08-12 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | MICHELLE MICHALOWSKI | PreparerPersonNm |
| PTIN | P00755304 | PTIN |
| Phone | 2024141000 | PhoneNum |
| Preparation | 2020-08-11 | PreparationDt |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 155.201.35.69 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federal Original Submission Id | 52580220202305000001 | FederalOriginalSubmissionId |
| Federal Original Submission Id | 2020-08-17 | FederalOriginalSubmissionIdDt |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | 5D86657B04133EFD86B5B0998D71DEAD23A9772A | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | C5BA7EE6C872918F72B1E375EC55F547D8B64602 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2020-09-23 17:36:50Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | DAVID M CHAO | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1000 EAST 50TH STREET | AddressLine1Txt |
| City | KANSAS CITY | CityNm |
| State Abbreviation | MO | StateAbbreviationCd |
| ZIP | 64110 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $168,628,194 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.STOWERS.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2005 | FormationYr |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Activity Or Mission | SIMR'S EXEMPT PURPOSE IS TO PERFORM MEDICAL RESEARCH IN THE PUBLIC INTEREST WITH THE GOAL OF EXPANDING OUR UNDERSTANDING OF THE FUNDAMENTAL PROCESSES OF LIVING CELLS. | ActivityOrMissionDesc |
| Voting Members Governing Body | 8 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 3 | VotingMembersIndependentCnt |
| Total Employee | 374 | TotalEmployeeCnt |
| Total Volunteers | 3 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $85,419,816 | PYContributionsGrantsAmt |
| CY Contributions Grants | $69,501,308 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $256,571 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $174,675 | CYProgramServiceRevenueAmt |
| PY Investment Income | $739,516 | PYInvestmentIncomeAmt |
| CY Investment Income | $2,937,748 | CYInvestmentIncomeAmt |
| PY Other Revenue | $108,655 | PYOtherRevenueAmt |
| CY Other Revenue | $835,747 | CYOtherRevenueAmt |
| PY Total Revenue | $86,524,558 | PYTotalRevenueAmt |
| CY Total Revenue | $73,449,478 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $975,000 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $34,934,899 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $36,569,659 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $50,028,333 | PYOtherExpensesAmt |
| CY Other Expenses | $55,133,761 | CYOtherExpensesAmt |
| PY Total Expenses | $85,938,232 | PYTotalExpensesAmt |
| CY Total Expenses | $91,703,420 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $586,326 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$18,253,942 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $335,909,539 | TotalAssetsBOYAmt |
| Total Assets EOY | $312,071,612 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $106,170,867 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $101,229,740 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $229,738,672 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $210,841,872 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $82,661,647 | ExpenseAmt |
| Revenue | $174,675 | RevenueAmt |
| Desc | SIMR'S ACCOMPLISHMENTS ARE DESCRIBED IN SCHEDULE O. | Desc |
| Total Program Service Expenses | $82,661,647 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | false | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (true) | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 31 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 374 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (true) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 8 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 3 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | false | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KATY GRAHAM | PersonNm |
| Phone | 8169264000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1000 E 50TH STREET | AddressLine1Txt |
| City | KANSAS CITY | CityNm |
| State Abbreviation | MO | StateAbbreviationCd |
| ZIP | 64110 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (15 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| RICHARD W BROWN | ||||||||
| DIRECTOR/CHAIR | 2.0 | 46.0 | Yes (X) | Yes (X) | $0 | $2,543,498 | $61,830 | |
| RODERICK L STURGEON | ||||||||
| DIRECTOR/CFO | 2.0 | 48.0 | Yes (X) | Yes (X) | $0 | $1,704,983 | $64,605 | |
| DAVID A WELTE | ||||||||
| DIRECTOR/SECRETARY | 2.0 | 48.0 | Yes (X) | Yes (X) | $0 | $1,425,034 | $70,740 | |
| DAVID M CHAO | ||||||||
| DIRECTOR/PRESIDENT/CEO | 40.0 | 4.0 | Yes (X) | Yes (X) | $1,370,171 | $0 | $43,446 | |
| ROBERT E KRUMLAUF - T | ||||||||
| DIR/SCIENTIFIC DIR EMERITUS | 40.0 | 4.0 | Yes (X) | $631,407 | $0 | $63,105 | ||
| BRENT KREIDER | ||||||||
| CHIEF OPERATING OFFICER | 2.0 | 40.0 | Yes (X) | $0 | $616,652 | $25,223 | ||
| R SCOTT HAWLEY | ||||||||
| INVESTIGATOR | 40.0 | 2.0 | $372,647 | $0 | $61,908 | Yes (X) | ||
| JERRY L WORKMAN | ||||||||
| INVESTIGATOR | 40.0 | 0.0 | $373,543 | $0 | $54,043 | Yes (X) | ||
| JOAN W CONAWAY | ||||||||
| INVESTIGATOR | 40.0 | 0.0 | $311,126 | $0 | $61,863 | Yes (X) | ||
| RONALD C CONAWAY | ||||||||
| INVESTIGATOR | 40.0 | 0.0 | $313,193 | $0 | $43,446 | Yes (X) | ||
| LINHENG LI | ||||||||
| INVESTIGATOR | 40.0 | 0.0 | $276,038 | $0 | $42,317 | Yes (X) | ||
| ALEJANDRO SANCHEZ ALVA | ||||||||
| DIR/SCIENTIFIC DIR FROM 7/2019 | 40.0 | 4.0 | Yes (X) | $154,210 | $0 | $16,751 | ||
| VIRGINIA G STOWERS | ||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| ALBERZINE FREEMAN | ||||||||
| DIRECTOR | 2.0 | 4.0 | Yes (X) | $0 | $0 | $0 | ||
| JONATHAN THOMAS | ||||||||
| DIRECTOR | 2.0 | 4.0 | Yes (X) | $0 | $0 | $0 | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,802,335 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $6,290,167 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $609,277 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 47 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (2 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| ETC GROUP LLC | |||||
| 1997 S 1100 E | SALT LAKE CITY | UT | 84106 | SOFTWARE DEVEL SRVCS | $242,840 |
| AMERICAN CENTURY INVESTMENTS | |||||
| 4500 MAIN ST | KANSAS CITY | MO | 64111 | INDIRECT - SEE SCH O | $169,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 2 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $63,100,000 | RelatedOrganizationsAmt |
| Government Grants | $5,608,271 | GovernmentGrantsAmt |
| All Other Contributions | $793,037 | AllOtherContributionsAmt |
| Noncash Contributions | $63,100,000 | NoncashContributionsAmt |
| Total Contributions | $69,501,308 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | COLLABORATION FEE FROM HHMI 501(C)(3) | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $174,675 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $174,675 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $174,675 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,654,052 | TotalRevenueColumnAmt |
| Exclusion | $1,654,052 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $775,726 | TotalRevenueColumnAmt |
| Exclusion | $775,726 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $15,304 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $15,304 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $96,340,208 | SecuritiesAmt |
| Other | $106,900 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $95,086,631 | SecuritiesAmt |
| Other | $76,781 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,253,577 | SecuritiesAmt |
| Other | $30,119 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,283,696 | TotalRevenueColumnAmt |
| Exclusion | $1,283,696 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | OTHER REBATES & REVENUE | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $60,021 | TotalRevenueColumnAmt |
| Exclusion | $60,021 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $60,021 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $73,449,478 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $174,675 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $3,773,495 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,279,090 | TotalAmt |
| Program Services | $2,051,181 | ProgramServicesAmt |
| Management And General | $227,909 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $782,159 | TotalAmt |
| Program Services | $703,943 | ProgramServicesAmt |
| Management And General | $78,216 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,432,159 | TotalAmt |
| Program Services | $21,988,943 | ProgramServicesAmt |
| Management And General | $2,443,216 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,539,143 | TotalAmt |
| Program Services | $2,285,229 | ProgramServicesAmt |
| Management And General | $253,914 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,845,937 | TotalAmt |
| Program Services | $4,361,343 | ProgramServicesAmt |
| Management And General | $484,594 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,691,171 | TotalAmt |
| Program Services | $1,522,054 | ProgramServicesAmt |
| Management And General | $169,117 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,166,109 | TotalAmt |
| Program Services | $1,049,498 | ProgramServicesAmt |
| Management And General | $116,611 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $141,679 | TotalAmt |
| Program Services | $127,511 | ProgramServicesAmt |
| Management And General | $14,168 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $340,358 | TotalAmt |
| Program Services | $306,322 | ProgramServicesAmt |
| Management And General | $34,036 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $386,412 | TotalAmt |
| Program Services | $347,771 | ProgramServicesAmt |
| Management And General | $38,641 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,215,247 | TotalAmt |
| Program Services | $1,993,722 | ProgramServicesAmt |
| Management And General | $221,525 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $891,238 | TotalAmt |
| Program Services | $802,114 | ProgramServicesAmt |
| Management And General | $89,124 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $697,978 | TotalAmt |
| Program Services | $628,180 | ProgramServicesAmt |
| Management And General | $69,798 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,625,997 | TotalAmt |
| Program Services | $8,663,397 | ProgramServicesAmt |
| Management And General | $962,600 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| COST-SHARING W/RELATED ORG | $30,443,614 | $27,399,253 | $3,044,361 |
| LAB SUPPLIES | $6,590,191 | $5,931,172 | $659,019 |
| PER CAPITA APPROP. TO GSSIMR | $1,285,700 | $1,285,700 | $0 |
| NON-CAPITAL EQUIPMENT | $465,867 | $419,280 | $46,587 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $883,371 | TotalAmt |
| Program Services | $795,034 | ProgramServicesAmt |
| Management And General | $88,337 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $91,703,420 | TotalAmt |
| Program Services | $82,661,647 | ProgramServicesAmt |
| Management And General | $9,041,773 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,897,970 | BOYAmt |
| EOY | $937,906 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $415,996 | BOYAmt |
| EOY | $470,714 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,287 | BOYAmt |
| EOY | $2,627 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $330,173 | BOYAmt |
| EOY | $375,470 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $333,055,015 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $194,728,136 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $141,078,865 | BOYAmt |
| EOY | $138,326,879 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $101,356,319 | BOYAmt |
| EOY | $85,997,459 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $373,601 | BOYAmt |
| EOY | $448,431 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $90,454,328 | BOYAmt |
| EOY | $85,512,126 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $335,909,539 | BOYAmt |
| EOY | $312,071,612 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,568,381 | BOYAmt |
| EOY | $9,773,789 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $202,716 | BOYAmt |
| EOY | $334,266 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $98,399,770 | BOYAmt |
| EOY | $91,121,685 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $106,170,867 | BOYAmt |
| EOY | $101,229,740 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $229,617,951 | BOYAmt |
| EOY | $210,635,494 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $120,721 | BOYAmt |
| EOY | $206,378 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $229,738,672 | BOYAmt |
| EOY | $210,841,872 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $335,909,539 | BOYAmt |
| EOY | $312,071,612 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$18,253,942 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$408,356 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$234,502 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp
Supported Organization Name SupportedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SEE SCHEDULE A | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | PART VI | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 4 | IN 2019, STOWERS INSTITUTE FOR MEDICAL RESEARCH ("SIMR") SCIENTISTS COLLABORATED WITH RESEARCHERS AT 70 NATIONAL AND 50 INTERNATIONAL INSTITUTIONS INCLUDING DOZENS OF HOSPITALS, MEDICAL CENTERS, AND MEDICAL SCHOOLS. MANY OF THESE COLLABORATIONS RESULTED IN DISCOVERIES THAT MERITED PUBLICATION IN LEADING PEER-REVIEWED SCIENTIFIC JOURNALS AND/OR SUCCESSFULLY FUNDED GRANT AWARDS. SIMR CONDUCTS MEDICAL RESEARCH IN CONJUNCTION WITH THE UNIVERSITY OF KANSAS (KU) AND ITS AFFILIATES THE UNIVERSITY OF KANSAS HOSPITAL AUTHORITY AND THE UNIVERSITY OF KANSAS MEDICAL CENTER (KUMC), PURSUANT TO A WRITTEN MEMORANDUM OF UNDERSTANDING. KUMC IS THE ACADEMIC HEALTH SCIENCE CENTER OF THE LARGEST PUBLIC RESEARCH UNIVERSITY IN THE STATE OF KANSAS. KUMC OFFERS PROGRAMS AND SERVICES THAT FOCUS ON EDUCATION, RESEARCH, PATIENT CARE, AND COMMUNITY ENGAGEMENT. AS OF DECEMBER 31, 2019, FIVE KUMC STUDENTS HAVE RECEIVED MS DEGREES AND 45 KUMC STUDENTS HAVE RECEIVED PHD DEGREES FOR THESIS WORK PERFORMED IN SIMR'S LABS. KUMC IS AFFILIATED WITH THE UNIVERSITY OF KANSAS HOSPITAL, A NONPROFIT INDEPENDENT HOSPITAL CO-LOCATED WITH THE MAIN KUMC CAMPUS IN KANSAS CITY, KS. IN 2019, TWENTY SIMR RESEARCH PROGRAM LEADERS WERE ADJUNCT FACULTY IN FOUR KUMC DEPARTMENTS. THESE APPOINTMENTS INCLUDED 12 FULL PROFESSORS, FOUR ASSOCIATE PROFESSORS, AND FOUR ASSISTANT PROFESSORS. IN 2019, 52 OF SIMR'S 74 ORIGINAL RESEARCH PUBLICATIONS INCLUDED BOTH SIMR AND KUMC AFFILIATIONS. ABOUT A DOZEN KUMC STUDENTS PERFORMED PREDOCTORAL RESEARCH IN SIMR LABS IN 2019. SIMR IS ALSO A CONSORTIUM MEMBER OF THE UNIVERSITY OF KANSAS CANCER CENTER AT KUMC, A CANCER RESEARCH AND CARE PARTNERSHIP SPANNING TWO STATES AND INVOLVING COLLABORATION AMONG RESEARCHERS, PHYSICIANS, AND CANCER SUPPORT PROFESSIONALS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH AREAS. IN JUNE 2012, THE NIH'S NATIONAL CANCER INSTITUTE (NCI) NAMED THE UNIVERSITY OF KANSAS CANCER CENTER A NCI-DESIGNATED CANCER CENTER. THE NCI CANCER CENTERS PROGRAM IS A PILLAR OF FEDERAL CANCER RESEARCH EFFORTS AND INTEGRAL TO THE NCI'S PROGRAMS FOR STUDYING, TREATING, AND PREVENTING CANCER. IN KUMC'S APPLICATION TO THE NCI CANCER CENTERS PROGRAM, $4 MILLION OF THE $48 MILLION IN GRANTS CITED IN THE APPLICATION WERE GRANTS THAT HAD BEEN AWARDED TO SIMR INVESTIGATORS. IN 2019, 12 SIMR RESEARCH PROGRAM LEADERS WERE MEMBERS OF THE UNIVERSITY OF KANSAS CANCER CENTER'S CANCER BIOLOGY RESEARCH PROGRAM, INCLUDING LINHENG LI, PHD, WHO SERVES AS CO-LEADER OF THE PROGRAM. IN 2019, SIMR RESEARCH PROGRAM LEADER MICHAEL WASHBURN, PHD, CONTINUED A RESEARCH PROJECT IN COLLABORATION WITH ROY JENSEN, MD, DIRECTOR OF THE UNIVERSITY OF KANSAS CANCER CENTER. THE OVERALL AIM OF THIS RESEARCH EFFORT IS TO DETERMINE HOW CANCER THERAPEUTICS ACT ON PROTEIN NETWORKS IN CELLS AND TISSUES. DR. JENSEN IS A WORLD-RENOWNED EXPERT ON BREAST CANCER AND HOLDS ADDITIONAL POSITIONS AS DIRECTOR, KANSAS MASONIC CANCER RESEARCH INSTITUTE, WILLIAM R. JEWELL DISTINGUISHED KANSAS MASONIC PROFESSOR, AND PROFESSOR OF PATHOLOGY AND LABORATORY MEDICINE, ANATOMY AND CELL BIOLOGY, CANCER BIOLOGY, AND MOLECULAR BIOSCIENCES AT KUMC. THE PROJECT AIMS TO FURTHER EXPLORE THE MECHANISM OF ACTION OF SUBEROYLANILIDE HYDROXAMIC ACID (SAHA), WHICH IS USED AS CHEMOTHERAPY FOR CERTAIN LYMPHOMAS AND IS BEING EVALUATED IN CLINICAL TRIALS FOR OTHER CANCERS. RECENT REPORTS SUGGEST THAT SAHA HAS ADDITIONAL EFFECTS THAT INVOLVE PROTEIN NETWORKS MORE BROADLY, THUS SUGGESTING OTHER POSSIBLE MECHANISMS OF ACTION. RESULTS FROM THIS JOINT RESEARCH EFFORT MAY ENABLE THE FUTURE DEVELOPMENT OF MORE SPECIFIC AND EFFECTIVE HUMAN THERAPEUTICS. THIS PROJECT IS SUPPORTED IN PART BY A NIH GRANT FROM THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES. IN 2019, SIMR RESEARCH PROGRAM LEADER LINHENG LI, PHD, CONTINUED A COLLABORATION WITH THE UNIVERSITY OF KANSAS CANCER CENTER AND CHILDREN'S MERCY HOSPITAL, KANSAS CITY, MO, TO INVESTIGATE APPROACHES TO TREAT LEUKEMIA. THIS RESEARCH FOCUSES ON TARGETING CANCER STEM CELLS TO HELP REDUCE THE RECURRENCE OF CANCER AFTER A PATIENT GOES INTO REMISSION. THE COLLABORATION BUILDS ON FOUNDATIONAL RESEARCH FROM THE LI LAB THAT HAS CHARACTERIZED CANCER STEM CELLS AT MOLECULAR AND CELLULAR LEVELS. THIS ONGOING RESEARCH COLLABORATION HAS GENERATED FINDINGS THAT HAVE BEEN REPORTED IN ORIGINAL RESEARCH PUBLICATIONS INCLUDING ZHAO M ET AL, 2019. KUMC IS THE SPONSOR OF A RELATED CLINICAL RESEARCH STUDY, "LOW-DOSE DAUNORUBICIN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA," WHICH IS DESIGNED TO ASSESS THE FEASIBILITY AND TOLERABILITY OF ADMINISTERING A LOW DOSE OF THE DRUG TO PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), AND TO OBTAIN PRELIMINARY DATA ON THE DRUG ENGAGING ITS TARGET. SIMR PARTICIPATED IN COLLABORATIONS CONDUCTING RESEARCH IN CONJUNCTION WITH THE FOLLOWING US HOSPITALS, PURSUANT TO AN UNDERSTANDING TO MAINTAIN CONTINUING CLOSE COOPERATION IN THE ACTIVE CONDUCT OF MEDICAL RESEARCH IN 2019: INSTITUTION LOCATION BRIGHAM AND WOMEN'S HOSPITAL BOSTON, MA CHILDREN'S HOSPITAL OF PHILADELPHIA PHILADELPHIA, PA CHILDREN'S MERCY HOSPITAL KANSAS CITY, MO CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER CINCINNATI, OH DANA-FARBER CANCER INSTITUTE BOSTON, MA FRED HUTCHINSON CANCER RESEARCH CENTER SEATTLE, WA GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES WASHINGTON, DC GREATER BALTIMORE MEDICAL CENTER TOWSON, MD HARVARD MEDICAL SCHOOL BOSTON, MA JOHNS HOPKINS SCHOOL OF MEDICINE BALTIMORE, MD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK, NY NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE CHICAGO, IL OREGON HEALTH AND SCIENCE UNIVERSITY SCHOOL OF MEDICINE PORTLAND, OR PERLMUTTER CANCER CENTER NEW YORK, NY SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE ST LOUIS, MO SEATTLE CHILDREN'S HOSPITAL SEATTLE, WA SINAI HOSPITAL OF BALTIMORE BALTIMORE, MD STANFORD UNIVERSITY SCHOOL OF MEDICINE PALO ALTO, CA UNIVERSITY OF CALIFORNIA LOS ANGELES DAVID GEFFEN SCHOOL OF MEDICINE LOS ANGELES, CA UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO, CA UNIVERSITY OF KANSAS CANCER CENTER KANSAS CITY, KS UNIVERSITY OF KANSAS MEDICAL CENTER KANSAS CITY, KS UNIVERSITY OF PENNSYLVANIA PERELMAN SCHOOL OF MEDICINE PHILADELPHIA, PA UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PA UNIVERSITY OF ROCHESTER MEDICAL CENTER ROCHESTER, NY UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE COLUMBIA, SC UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER MEMPHIS, TN UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER HOUSTON, TX WEILL CORNELL MEDICINE NEW YORK, NY TO CARRY OUT THE RESEARCH DESCRIBED IN THE FOLLOWING EXAMPLES, SIMR AND HOSPITAL, MEDICAL CENTER, OR MEDICAL SCHOOL ENTERED INTO A COOPERATION AGREEMENT PURSUANT TO WHICH THEY AGREED TO ESTABLISH, DEVELOP, ADMINISTER, AND MAINTAIN CONTINUING CLOSE COOPERATION IN THE ACTIVE CONDUCT OF MEDICAL RESEARCH, INCLUDING THROUGH SPECIFIC COOPERATIVE EFFORTS IN THE AREAS OF RESEARCH, SHARING OF INFORMATION, PURSUANT OF JOINT GRANTS, INTERACTION OF STAFF, ADJUNCT/JOINT APPOINTMENTS, AND SHARING OF FACILITIES. IN ORDER TO ASSURE THE SUCCESS OF THEIR COOPERATIVE RELATIONSHIP, EACH AGREED TO ENGAGE IN EFFECTIVE, COORDINATED AND ONGOING PLANNING, OVERSIGHT, AND COMMUNICATION, AND TO COMMIT THE NECESSARY RESOURCES, BOTH HUMAN AND MONETARY, TO SUPPORT, FACILITATE, AND PROMOTE THE COOPERATION. |
| JOINT MEDICAL RESEARCH ON THE CHARACTERIZATION OF INTESTINAL STEM CELLS - | THE LI LAB PERFORMED JOINT MEDICAL RESEARCH ON THE CHARACTERIZATION OF INTESTINAL STEM CELLS WITH COLLABORATORS AT CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA, OREGON HEALTH AND SCIENCE UNIVERSITY SCHOOL OF MEDICINE, STANFORD UNIVERSITY SCHOOL OF MEDICINE, AND UNIVERSITY OF PITTSBURGH CANCER INSTITUTE. INTESTINAL DISEASES RANGING FROM CROHN'S DISEASE TO COLITIS TO CANCER MAY BENEFIT FROM INTESTINAL STEM CELL THERAPIES. THIS RESEARCH ADVANCES THE UNDERSTANDING OF THE BIOLOGY OF STEM CELLS THAT RESIDE IN THE INTESTINE AND EXPLORES HOW THEY CAN BE USED TO TREAT AND CURE INTESTINAL DISEASES. THIS ONGOING RESEARCH COLLABORATION IS SUPPORTED IN PART BY A NIH GRANT AWARDED BY THE NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES. JOINT MEDICAL RESEARCH ON EYE DEVELOPMENT AND FUNCTION - THE XIE LAB PERFORMED JOINT MEDICAL RESEARCH ON GENETIC PROGRAMS THAT REGULATE THE MAMMALIAN EYE WITH COLLABORATORS AT CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, UNIVERSITY OF ROCHESTER MEDICAL CENTER, AND KYOTO UNIVERSITY. AN EYE STRUCTURE CALLED THE CILIARY BODY IS IMPORTANT FOR CHANGING THE SHAPE OF THE LENS AND FOR PRODUCTION OF THE AQUEOUS HUMOR, THE FLUID THAT MAINTAINS PRESSURE IN THE EYE. DEFECTS IN LENS ACCOMMODATION LEAD TO MYOPIA OR NEARSIGHTEDNESS, WHILE HIGH PRESSURE WITHIN THE EYE IS ONE OF THE MOST IMPORTANT RISK FACTORS FOR GLAUCOMA, THE SECOND LEADING BLIND-CAUSING DISEASE. THE GOAL OF THIS RESEARCH IS TO REVEAL THE MECHANISMS REGULATING THE DEVELOPMENT AND SECRETION OF THE CILIARY BODY. KNOWLEDGE GAINED FROM THESE STUDIES MAY ENHANCE TREATMENTS FOR GLAUCOMA AND MYOPIA. THIS RESEARCH IS SUPPORTED IN PART BY A NIH GRANT FROM THE NATIONAL EYE INSTITUTE. OTHER US COLLABORATORS INCLUDED BERNICE PAUAHI BISHOP MUSEUM, BOSTON COLLEGE, CALIFORNIA INSTITUTE OF TECHNOLOGY, COLD SPRING HARBOR LABORATORY, CORNELIA DE LANGE SYNDROME FOUNDATION, ELMHURST COLLEGE, FLORIDA ATLANTIC UNIVERSITY, HOWARD HUGHES MEDICAL INSTITUTE, INDIANA UNIVERSITY, JOHNS HOPKINS UNIVERSITY, LAWRENCE BERKELEY LABORATORY, MARQUETTE UNIVERSITY, MILLERSVILLE UNIVERSITY, MORGRIDGE INSTITUTE FOR RESEARCH, NATIONAL CANCER INSTITUTE OF THE NATIONAL INSTITUTES OF HEALTH, NATURAL HISTORY MUSEUM OF LOS ANGELES COUNTY, NEW YORK STATE DEPARTMENT OF HEALTH, NEW YORK UNIVERSITY, OPEN UNIVERSITY, PRINCETON UNIVERSITY, PURDUE UNIVERSITY, RUTGERS UNIVERSITY, SOUTHEASTERN LOUISIANA UNIVERSITY, UNIVERSITY OF CALIFORNIA DAVIS, UNIVERSITY OF CALIFORNIA IRVINE, UNIVERSITY OF CALIFORNIA MERCED, UNIVERSITY OF CALIFORNIA SAN DIEGO, UNIVERSITY OF FLORIDA ST AUGUSTINE, UNIVERSITY OF FLORIDA GAINESVILLE, UNIVERSITY OF KANSAS, UNIVERSITY OF KENTUCKY, UNIVERSITY OF MARYLAND, UNIVERSITY OF MINNESOTA, UNIVERSITY OF MISSOURI-KANSAS CITY, UNIVERSITY OF PITTSBURGH, UNIVERSITY OF TEXAS AT ARLINGTON, UNIVERSITY OF VIRGINIA, UNIVERSITY OF WASHINGTON, UNIVERSITY OF WISCONSIN-MADISON, VIRGINIA COMMONWEALTH UNIVERSITY, AND WASHINGTON UNIVERSITY IN ST LOUIS. SIMR COLLABORATED WITH THE FOLLOWING INTERNATIONAL HOSPITALS, MEDICAL CENTERS, AND MEDICAL SCHOOLS IN 2019: BEIJING PERFECT FAMILY HOSPITAL, CHINA; CHINESE ACADEMY OF MEDICAL SCIENCES, TIANJIN, CHINA; HENAN PROVINCIAL PEOPLE'S HOSPITAL, ZHENGZHOU, CHINA; HONG KONG BAPTIST UNIVERSITY, CHINA; HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY, CHINA; PEKING UNION MEDICAL COLLEGE, TIANJIN, CHINA; THIRD AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY, GUANGZHOU, CHINA; TIANJIN MEDICAL UNIVERSITY, HEPING, CHINA; TSINGHUA UNIVERSITY SCHOOL OF MEDICINE,BEIJING, CHINA; WUHAN NO.1 HOSPITAL, HUBEI, CHINA; AND ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE, HANGZHOU, CHINA. OTHER INTERNATIONAL COLLABORATORS INCLUDED AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH, SINGAPORE; BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY, SPAIN; CARDIFF UNIVERSITY, CATHAYS, UNITED KINGDOM; CENTRO DE INVESTIGACION BIOMEDICA EN RED EN BIOINGENIERIA, MADRID, SPAIN; CIENCIAS BIOLOGICAS, QUITO, ECUADOR; CZECH ACADEMY OF SCIENCES, PRAGUE; DURHAM UNIVERSITY, UNITED KINGDOM; ECOLE POLYTECHNIQUE, PALAISEAU, FRANCE; FRIEDRICH MIESCHER LABORATORY OF THE MAX PLANCK SOCIETY, TUBINGEN, GERMANY; HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY, WUHAN, HUBEI, CHINA; HUBEI UNIVERSITY, WUHAN, CHINA; INSTITUTO DE FISIOLOGIA, MENDOZA, ARGENTINA; INSTITUTO DE HISTOLOGIA Y EMBRIOLOGIA, MENDOZA, ARGENTINA; INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY, BRAGA, PORTUGAL; ISRAEL INSTITUTE OF TECHNOLOGY, HAIFA; JILIN UNIVERSITY, CHANGCHUN, CHINA; KIEL UNIVERSITY, GERMANY; KYOTO UNIVERSITY, JAPAN; MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY, PLON, GERMANY; MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS, DRESDEN, GERMANY; NATIONAL RESEARCH COUNCIL, PISA, ITALY; OSAKA UNIVERSITY, JAPAN; RESEARCH CENTRE FOR MEDICAL GENETICS, MOSCOW, RUSSIA; SEJONG UNIVERSITY, SEOUL, KOREA; SHENZHEN UNIVERSITY, CHINA; SUN YAT-SEN UNIVERSITY, GUANGZHOU, CHINA; TEL AVIV UNIVERSITY, ISRAEL; TOHOKU UNIVERSITY, SENDAI, JAPAN; TSINGHUA UNIVERSITY, BEIJING, CHINA; UNIVERSITY OF HELSINKI, FINLAND; UNIVERSITY OF MILAN, ITALY; UNIVERSITY OF SASKATCHEWAN, SASKATOON, CANADA; UNIVERSITY OF SCIENCE AND TECHNOLOGY, HONG KONG, CHINA; UNIVERSITY OF TOKYO, JAPAN; UNIVERSITY OF TORONTO, CANADA; UNIVERSITY OF WURZBURG, GERMANY; UNIVERSITY OF ZURICH, SWITZERLAND; WELLCOME SANGER INSTITUTE, HINXTON, UNITED KINGDOM; AND YONSEI UNIVERSITY COLLEGE OF DENTISTRY, SEOUL, KOREA. |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $120,721 | BeginningYearBalanceAmt |
| Contributions | $163,200 | ContributionsAmt |
| Other Expenditures | $77,543 | OtherExpendituresAmt |
| End Year Balance | $206,378 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $550,240 | BeginningYearBalanceAmt |
| Contributions | $75,000 | ContributionsAmt |
| Other Expenditures | $504,519 | OtherExpendituresAmt |
| End Year Balance | $120,721 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $626,653 | BeginningYearBalanceAmt |
| Contributions | $100,000 | ContributionsAmt |
| Other Expenditures | $176,413 | OtherExpendituresAmt |
| End Year Balance | $550,240 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $39,191 | BeginningYearBalanceAmt |
| Contributions | $661,216 | ContributionsAmt |
| Other Expenditures | $73,754 | OtherExpendituresAmt |
| End Year Balance | $626,653 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $0 | BeginningYearBalanceAmt |
| Contributions | $100,000 | ContributionsAmt |
| Other Expenditures | $60,809 | OtherExpendituresAmt |
| End Year Balance | $39,191 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Term Endowment Balance EOY | 1.00000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $3,400,000 | OtherCostOrOtherBasisAmt |
| Book Value | $3,400,000 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $232,820,072 | OtherCostOrOtherBasisAmt |
| Depreciation | $115,655,967 | DepreciationAmt |
| Book Value | $117,164,105 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Leasehold Improvements | LeaseholdImprovementsGrp |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $95,244,723 | OtherCostOrOtherBasisAmt |
| Depreciation | $79,072,169 | DepreciationAmt |
| Book Value | $16,172,554 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,590,220 | OtherCostOrOtherBasisAmt |
| Book Value | $1,590,220 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $138,326,879 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (2 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| ANNUITY REC. FROM AFFILIATE | $85,435,085 |
| OTHER RECEIVABLES | $77,041 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $85,512,126 | TotalBookValueOtherAssetsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)
| DescDesc | AmtAmt |
|---|---|
| ADVANCES FROM AFFILIATES | $7,243,770 |
| PAYABLE FOR GIFT ANNUITY | $83,657,244 |
| PAYABLE TO GSSIMR | $32,058 |
| COMPENSATION EXCISE TAX | $188,613 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $91,121,685 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, LINE 4: | THE ENDOWMENT IS FROM A SINGLE DONOR TO CONTRIBUTE FUNDING TOWARDS AN ESTABLISHED LECTURE SERIES PROGRAM WHERE SIMR HOSTS SCIENCE SPEAKERS FROM OTHER RESEARCH INSTITUTIONS AND UNIVERSITIES TO ENCOURAGE COLLABORATIVE SCIENCE OPPORTUNITIES WITH TOP SCIENTISTS FROM AROUND THE WORLD. |
| PART X, LINE 2: | FIN 48 FINANCIAL STATEMENT FOOTNOTE FROM THE CONSOLIDATED STATEMENTS OF STOWERS INSTITUTE FOR MEDICAL RESEARCH (THE INSTITUTE) IS AS FOLLOWS: THE INSTITUTE RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | Yes (true) | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DAVID A WELTE | ||||||||||||||
| DIRECTOR/SECRETARY | $0 | $1,368,976 | $0 | $0 | $0 | $56,058 | $0 | $42,000 | $0 | $28,740 | $0 | $1,495,774 | $0 | $0 |
| RODERICK L STURGEON | ||||||||||||||
| DIRECTOR/CFO | $0 | $1,597,472 | $0 | $0 | $0 | $107,511 | $0 | $42,000 | $0 | $22,605 | $0 | $1,769,588 | $0 | $0 |
| DAVID M CHAO | ||||||||||||||
| DIRECTOR/PRESIDENT/CEO | $1,360,250 | $0 | $0 | $0 | $9,921 | $0 | $42,000 | $0 | $1,446 | $0 | $1,413,617 | $0 | $0 | $0 |
| ROBERT E KRUMLAUF - TO 72019 | ||||||||||||||
| DIR/SCIENTIFIC DIR EMERITUS | $437,532 | $0 | $0 | $0 | $193,875 | $0 | $42,000 | $0 | $21,105 | $0 | $694,512 | $0 | $0 | $0 |
| RICHARD W BROWN | ||||||||||||||
| DIRECTOR/CHAIR | $0 | $2,516,009 | $0 | $0 | $0 | $27,489 | $0 | $42,000 | $0 | $19,830 | $0 | $2,605,328 | $0 | $0 |
| ALEJANDRO SANCHEZ ALVARADO | ||||||||||||||
| DIR/SCIENTIFIC DIR FROM 7/2019 | $153,849 | $0 | $0 | $0 | $361 | $0 | $16,350 | $0 | $401 | $0 | $170,961 | $0 | $0 | $0 |
| BRENT KREIDER | ||||||||||||||
| CHIEF OPERATING OFFICER | $0 | $607,808 | $0 | $0 | $0 | $8,844 | $0 | $0 | $0 | $25,223 | $0 | $641,875 | $0 | $0 |
| RONALD C CONAWAY | ||||||||||||||
| INVESTIGATOR | $309,629 | $0 | $0 | $0 | $3,564 | $0 | $42,000 | $0 | $1,446 | $0 | $356,639 | $0 | $0 | $0 |
| JOAN W CONAWAY | ||||||||||||||
| INVESTIGATOR | $307,562 | $0 | $0 | $0 | $3,564 | $0 | $42,000 | $0 | $19,863 | $0 | $372,989 | $0 | $0 | $0 |
| JERRY L WORKMAN | ||||||||||||||
| INVESTIGATOR | $369,979 | $0 | $0 | $0 | $3,564 | $0 | $42,000 | $0 | $12,043 | $0 | $427,586 | $0 | $0 | $0 |
| R SCOTT HAWLEY | ||||||||||||||
| INVESTIGATOR | $368,456 | $0 | $0 | $0 | $4,191 | $0 | $42,000 | $0 | $19,908 | $0 | $434,555 | $0 | $0 | $0 |
| LINHENG LI | ||||||||||||||
| INVESTIGATOR | $272,474 | $0 | $0 | $0 | $3,564 | $0 | $40,871 | $0 | $1,446 | $0 | $318,355 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A: | SIMR HAS A WRITTEN EMPLOYMENT AGREEMENT WITH DAVID M. CHAO, WHICH PROVIDES FOR TAXABLE TERM LIFE BENEFITS AND FOR HIM TO RECEIVE TAX GROSS-UP PAYMENTS SUFFICIENT TO COVER THE TAXES ON THESE BENEFITS. |
| PART I, LINE 1B: | SIMR PROVIDED THE BENEFITS DESCRIBED IN RESPONSE TO LINE 1A PURSUANT TO WRITTEN EMPLOYMENT CONTRACTS THAT WAS APPROVED BY SIMR'S GOVERNING BOARD. SEE RESPONSE TO FORM 990, PART VI, SECTION B, LINE 15, FOR ADDITIONAL PROCESSES RELATED TO DETERMINING EXECUTIVE COMPENSATION. |
| PART I, LINE 5A: | SIMR MADE A PAYMENT OF $188,931 TO ROBERT E. KRUMLAUF, SCIENTIFIC DIRECTOR. THIS PAYMENT REPRESENTS THE PORTION OF THE NET ROYALTIES RECEIVED BY SIMR FOR LICENSED SCIENTIFIC DISCOVERY TECHNOLOGY THAT IS PAYABLE TO ROBERT E. KRUMLAUF, PH.D., FOR HIS PARTICIPATION IN THE DISCOVERY. |
| PART II, LINES 4 AND 6: | ROBERT KRUMLAUF SERVED AS SIMR'S SCIENTIFIC DIRECTOR THROUGH JUNE 30, 2019, AFTER WHICH HE BECAME SCIENTIFIC DIRECTOR EMERITUS. ALEJANDRO SANCHEZ ALVARADO BECAME SIMR'S SCIENTIFIC DIRECTOR ON JULY 1, 2019. |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (3 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| JULIA ZEITLINGER PHD | |||
| SEE PART V | $263,391 | EMPLOYEE OF SIMR | false |
| LEANNE WIEDEMANN PHD | |||
| SEE PART V | $267,756 | EMPLOYEE OF SIMR | false |
| TATJANA PIOTROWSKI PHD | |||
| SEE PART V | $251,012 | EMPLOYEE OF SIMR | false |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART IV, LINES (1) , (2) & (3): | FormAndLineReferenceDesc |
| Explanation | JULIA ZEITLINGER, PH.D, IS THE SPOUSE OF DAVID M. CHAO, PRESIDENT OF SIMR. MS. ZEITLINGER IS AN ASSOCIATE INVESTIGATOR AT SIMR. MS. ZEITLINGER'S PREVIOUS EMPLOYMENT BEFORE SIMR WAS WITH THE WHITEHEAD INSTITUTE FOR MEDICAL RESEARCH WHERE SHE WAS THE RECIPIENT OF A PREDOCTORAL FELLOWSHIP FROM THE HUMAN FRONTIER SCIENCE PROGRAM. LEANNE WIEDMANN, PH.D, IS THE SPOUSE OF ROBERT KRUMLAUF, SCIENTIFIC DIRECTOR EMERITUS OF SIMR. MS. WIEDEMANN PERFORMS INDEPENDENT SCIENCE RESEARCH AT SIMR AND IS CONCURRENTLY A PROFESSOR AT THE UNIVERSITY OF KANSAS MEDICAL CENTER IN THE DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. TATJANA PIOTROWSKI, PH.D, IS THE SPOUSE OF ALEJANDRO SANCHEZ ALVARADO, DIRECTOR AND SCIENTIFIC DIRECTOR OF SIMR AS OF JULY 2019. MS. PIOTROWSKI IS AN INVESTIGATOR AT SIMR. HER PREVIOUS EMPLOYMENT BEFORE SIMR WAS WITH THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE WHERE SHE WAS AN ASSOCIATE PROFESSOR IN THE DEPARTMENT OF NEUROBIOLGOY AND ANATOMY. | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 3 | ContributionCnt |
| Noncash Contributions Rpt F990 | $63,100,000 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FAIR MARKET VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp | |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN B: | FormAndLineReferenceDesc |
| Explanation | THE AMOUNTS SHOWN IN PART I, COLUMN (B) FOR "NUMBER OF CONTRIBUTIONS" REPRESENTS THE TOTAL NUMBER OF CONTRIBUTIONS AND NOT NECESSARILY THE TOTAL NUMBER OF ITEMS CONTRIBUTED. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART III, LINE 1: | THE STOWERS INSTITUTE FOR MEDICAL RESEARCH ("SIMR") PERFORMS MEDICAL RESEARCH IN THE PUBLIC INTEREST WITH THE GOAL OF EXPANDING THE UNDERSTANDING OF FUNDAMENTAL PROCESSES IN LIVING CELLS AND IMPROVING LIFE'S QUALITY THROUGH INNOVATIVE APPROACHES TO THE CAUSES, TREATMENT, AND PREVENTION OF DISEASE. PART III, LINE 4: SIMR'S ACCOMPLISHMENTS ARE DESCRIBED AT THE END OF SCHEDULE O. PART VI, LINE 2: VIRGINIA G. STOWERS, JONATHAN THOMAS, RICHARD W. BROWN, DAVID A. WELTE, DAVID M. CHAO, ALBERZINE FREEMAN, AND ALEJANDRO SANCHEZ ALVARADO, ALL DIRECTORS OF SIMR, HAVE A BUSINESS RELATIONSHIP. JONATHAN THOMAS, RICHARD W. BROWN, DAVID A. WELTE, DAVID M. CHAO, RODERICK L. STURGEON, AND ALBERZINE FREEMAN, DIRECTORS OF SIMR, AND BRENT KREIDER, OFFICER OF SIMR, HAVE A BUSINESS RELATIONSHIP. DAVID A. WELTE, RICHARD W. BROWN, AND RODERICK L. STURGEON, DIRECTORS OF SIMR, AND BRENT KREIDER, OFFICER OF SIMR, HAVE A BUSINESS RELATIONSHIP. PART VI, LINE 11B: THE DATA AND INFORMATION NECESSARY TO PREPARE SIMR'S FORM 990 WAS COMPILED BY SIMR'S ACCOUNTING DEPARTMENT AND THEN REVIEWED BY THE INSTITUTE'S S TAX ATTORNEY AT BRYAN CAVE LEIGHTON PAISNER, LLP. PRICEWATERHOUSECOOPERS ("PWC"), THE INSTITUTE'S EXTERNAL TAX PREPARERS, USED THIS INFORMATION TO PREPARE THE FORM 990. THE COMPLETED FORM 990, INCLUDING REQUIRED SCHEDULES, IS REVIEWED BY THE OFFICERS OF SIMR BEFORE IT IS FILED WITH THE IRS. AFTER THE PREPARATION AND REVIEW PROCESS DESCRIBED ABOVE, THE FORM 990, INCLUDING REQUIRED SCHEDULES, IS PROVIDED TO EACH VOTING MEMBER OF THE ORGANIZATION'S BOARD BEFORE IT IS FILED WITH THE IRS. PART VI, LINE 12C: SIMR HAS ADOPTED A "CONFLICTS OF INTEREST AND DIRECTOR INDEPENDENCE POLICY". EACH DIRECTOR, OFFICER, AND ALL OTHER PERSONS IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER DECISIONS OF SIMR ARE REQUIRED TO ANNUALLY COMPLETE AND SIGN A DISCLOSURE STATEMENT THAT IS PART OF THE POLICY. A COVERED PERSON MUST ALSO DISCLOSE THE EXISTENCE OF A POTENTIAL CONFLICT AND ALL MATERIAL FACTS TO THE GOVERNING BOARD AS SOON AS THE PERSON HAS KNOWLEDGE THAT A POTENTIAL CONFLICT MIGHT EXIST. SIMR CONDUCTS PERIODIC AND ADHOC REVIEWS OF TRANSACTIONS AND AGREEMENTS TO ENSURE THAT IT ENGAGES ONLY IN ACTIVITIES THAT ARE CONSISTENT WITH ITS TAX-EXEMPT PURPOSE. FORM 990, PART VI, LINE 15A: THE COMPENSATION FOR DAVID CHAO, THE PRESIDENT AND CEO OF SIMR, WAS ESTABLISHED PURSUANT TO THE PROCEDURES OF TREAS. REG. SECTION 53.4958- 6, INCLUDING (1) REVIEW AND APPROVAL BY SIMR'S COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT PERSONS, (2) RELYING ON COMPARABILITY DATA, INCLUDING DATA PREPARED BY A NATIONALLY KNOWN COMPENSATION CONSULTANT REGARDING COMPARABLE SALARY AND BENEFITS FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS, AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORD KEEPING OF THE DELIBERATION AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. THIS PROCESS WAS LAST UNDERTAKEN IN 2019. PART VI, LINE 19: SIMR'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. PART VII, SECTION A, COLUMN B: DAVID M. CHAO, OFFICER OF SIMR, AND R. SCOTT HAWLEY, EMPLOYEE OF SIMR, ALSO PERFORM SUPPORT SERVICES FOR ONE OR MORE OF THE RELATED ORGANIZATIONS DISCLOSED IN SCHEDULE R. THESE SERVICES ARE PERFORMED IN THEIR ROLE AS SIMR EMPLOYEES AND SIMR IS REIMBURSED BY THE RELATED ORGANIZATIONS. PART VII, SECTION B: SIMR RECEIVES INVESTMENT MANAGEMENT SERVICES FROM AMERICAN CENTURY INVESTMENTS ("ACI"). ACI IS A WHOLLY OWNED SUBSIDIARY OF AMERICAN CENTURY COMPANIES, INC. ("ACCI"). IN SELECTING ACI TO MANAGE ITS LIQUID INVESTMENTS, SIMR NOT ONLY CHOSE A HIGH QUALITY MUTUAL FUND COMPANY WITH AN OUTSTANDING TRACK RECORD, BUT ALSO PLACED ITS LIQUID INVESTMENTS IN A COMPANY IN WHICH IT OWNS STOCK AND RECEIVES DIVIDENDS. SIMR PAYS ACI THE SAME ADMINISTRATIVE FEES FOR THESE SERVICES AS ANY ARMS-LENGTH INVESTOR.THOSE INVESTMENT FEES FOR A SHARED INVESTMENT POOL ARE PAID BY ITS SUPPORTING ORGANIZATION, STOWERS RESOURCE MANAGEMENT. PART XI, LINE 9: OTHER CHANGES IN NET ASSETS INCLUDE THE FOLLOWING: CHANGE IN ANNUITY RECEIVABLE, NET ($234,502) |
| PART III, LINE 4A | 2019 PROGRAM SERVICE ACCOMPLISHMENTS THE STOWERS INSTITUTE FOR MEDICAL RESEARCH ("SIMR") IS A PRIVATE, NONPROFIT MEDICAL RESEARCH ORGANIZATION. SIMR WAS FOUNDED IN 1994 BY JIM AND VIRGINIA STOWERS, WHO EACH SURVIVED A BOUT WITH CANCER AND SUBSEQUENTLY DEDICATED THEIR FORTUNE TO SUPPORTING BASIC RESEARCH IN CELL AND MOLECULAR BIOLOGY THAT WILL PROVIDE LONG-TERM SOLUTIONS TO HUMAN DISEASES. SIMR CONDUCTS BASIC BIOMEDICAL RESEARCH IN THE PUBLIC INTEREST THAT WILL ULTIMATELY PROVIDE A GREATER UNDERSTANDING OF THE GENES AND PROTEINS THAT CONTROL HOW CELLS IN OUR BODIES MULTIPLY, FORM TISSUES, AND DIE. STUDYING THE BASIC BIOLOGY OF CELLS ENABLES SCIENTISTS TO DISCOVER HOW GENES CAUSE MANY DISEASES, INCLUDING CANCER, BIRTH DEFECTS, AND DEMENTIA. HISTORY HAS SHOWN THAT BASIC MEDICAL RESEARCH IS OFTEN A KEY FIRST STEP IN THE DEVELOPMENT OF NEW TREATMENTS, CURES, AND PREVENTIONS FOR MANY HUMAN DISEASES. 2019 NOTABLE RESEARCH RESULTS IN 2019, SIMR RESEARCH TEAMS MADE DISCOVERIES MERITING PUBLICATION IN LEADING PEER-REVIEWED SCIENTIFIC JOURNALS - 74 ORIGINAL RESEARCH PAPERS IN ALL. SIMR RESEARCH TEAMS ALSO PRODUCED 34 OTHER PUBLICATIONS INCLUDING REVIEWS, COMMENTARIES, BOOK CHAPTERS, AND BOOKS. SOME OF THE HIGHLIGHTS AMONG THESE PAPERS AND OTHER ADVANCES INVOLVING STOWERS RESEARCH INCLUDE THE FOLLOWING: THE KRUMLAUF LAB HELPED LAY THE GROUNDWORK FOR A NEW APPROACH TO TREATING OSTEOPOROSIS WITH AN UNEXPECTED DISCOVERY MADE NEARLY TWO DECADES AGO. AFTER UNCOVERING A MECHANISM THAT CONTROLS BONE GROWTH, THEIR WORK WAS PATENTED AND THE INTELLECTUAL PROPERTY LICENSED TO AMGEN IN 2005. AMGEN USED THAT FINDING AS WELL AS OTHERS' RESEARCH ABOUT BONE GROWTH TO DEVELOP A NEW DRUG, ROMOSOZUMAB. TWO PHASE 3 CLINICAL TRIALS SHOWED A SIGNIFICANT REDUCTION OF FRACTURES. THE DRUG ALSO INCREASED BONE DENSITY IN THE SPINES OF STUDY PARTICIPANTS BY AROUND 15%. ROMOSOZUMAB, THE FIRST NEW DRUG AIDED BY RESEARCH FROM SIMR, WAS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION IN JANUARY 2019. THE LI LAB PUBLISHED A STUDY DESCRIBING HOW BLOOD-FORMING ADULT STEM CELLS REPOPULATE AFTER CHEMOTHERAPY. THESE CELLS, CALLED "RESERVE" HEMATOPOIETIC STEM CELLS, RESIDE IN BONE MARROW. THEY ARE RESPONSIBLE FOR REGENERATING THE BODY'S BLOOD SUPPLY, REPOPULATING AFTER CHEMOTHERAPY OR INJURY DEPLETES THEIR NUMBERS. THE FINDINGS MAY OPEN NEW AVENUES FOR TREATING BLOOD DISEASES LIKE LEUKEMIA AND AUTOIMMUNE DISORDERS. THE STUDY WAS PUBLISHED ONLINE JANUARY 15, 2019, IN CELL REPORTS. THE WASHBURN LAB CREATED A TOPOLOGICAL SCORING (TOPS) ALGORITHM, WHICH ALLOWS SCIENTISTS TO LOOK AT BIG SETS OF DATA IN NEW WAYS. THIS HELPS SCIENTISTS UNCOVER MORE DETAILS ABOUT HOW PROTEINS INTERACT AND UNDERSTAND HOW CERTAIN ACTIVITIES ON THE CELLULAR LEVEL HAPPEN. THE REPORT WAS PUBLISHED IN THE MARCH 8, 2019, ISSUE OF NATURE COMMUNICATIONS. THE BAZZINI LAB SHOWED THAT IN HUMAN CELL LINES, RIBOSOMES PLAY AN ACTIVE ROLE IN REGULATING MRNAS - THE MESSAGES THAT RIBOSOMES READ TO MAKE PROTEINS. THE STUDY ALSO PROVIDES EVIDENCE FOR ANOTHER LAYER OF INFORMATION WITHIN THE MESSAGES THAT CAN AFFECT MRNA LEVELS AND STABILITY. UNDERSTANDING THE REGULATORY FUNCTION OF RIBOSOMES IN MODULATING GENE EXPRESSION IN HUMAN CELLS CAN PROVIDE INSIGHT ABOUT CAUSES OF GENE MISREGULATION, WHICH CAN SOMETIMES LEAD TO HUMAN DISEASES. THE FINDINGS WERE PUBLISHED ONLINE APRIL 23, 2019, IN ELIFE. THE GERTON LAB UNCOVERED AN ANSWER TO A CENTURIES-OLD QUESTION OF HOW CONNECTIONS BETWEEN PARTICULAR HUMAN CHROMOSOMES MIGHT BE BUILT. THESE INTER-CHROMOSOMAL CONNECTIONS ARE COMPOSED OF RIBOSOMAL DNA WITH A SHARED SEQUENCE. THE FINDINGS SUGGEST THAT THE CONNECTIONS ARE CONTROLLED BY THE PROXIMITY OF THE CHROMOSOMES IN THREE-DIMENSIONAL SPACE AND THEIR TRANSCRIPTION, WHICH TOGETHER ALLOW CHROMOSOMES TO BUMP INTO EACH OTHER AND BECOME INTERLOCKED. THE FINDINGS COULD PROVIDE CLUES ABOUT THE ORIGINS OF CHROMOSOMAL FUSIONS ASSOCIATED WITH INFERTILITY AND DEVELOPMENTAL DISORDERS IN HUMANS. THE ARTICLE WAS PUBLISHED JULY 23, 2019, IN THE JOURNAL OF CELL BIOLOGY. THE GIBSON LAB PUBLISHED RESEARCH HIGHLIGHTING THE IMPORTANCE OF UNIFORM CELL SIZE IN MAINTAINING THE ARCHITECTURE OF EPITHELIAL SHEETS. ABNORMALLY SMALL EPITHELIAL CELLS CAN DISSOCIATE FROM EACH OTHER AND DISPERSE AMONG NORMAL CELLS. A SERIES OF EXPERIMENTS SHOWED THAT ABNORMAL SMALL-CELL DISPERSAL RESULTS FROM GEOMETRIC EFFECTS OF CELL SIZE VARIATION ON EPITHELIAL PACKING. THESE FINDINGS MAY FURTHER THE UNDERSTANDING OF HUMAN DISEASE PROGRESSION. THE STUDY WAS PUBLISHED ONLINE SEPTEMBER 5, 2019, IN DEVELOPMENTAL CELL. THE HAWLEY LAB DISCOVERED MORE DETAILS ABOUT HOW THE SYNAPTONEMAL COMPLEX IN MEIOSIS PERFORMS ITS JOB. THIS LARGE PROTEIN COMPLEX IS A CRITICAL PLAYER IN THE SEGREGATION OF CHROMOSOMES DURING MEIOSIS. EXPERIMENTS INDICATED THAT THE X CHROMOSOME OF THE FRUIT FLY IS SENSITIVE TO DEFECTS IN THE STRUCTURE OF THE SYNAPTONEMAL COMPLEX, WITH EFFECTS VARYING DEPENDING PARTLY ON THE STAGE OF MEIOSIS. THE RESEARCH MAY HELP FURTHER UNDERSTANDING OF THE CAUSES OF HUMAN MISCARRIAGE. THE WORK WAS PUBLISHED ONLINE SEPTEMBER 30, 2019, IN THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. THE WASHBURN LAB UNCOVERED NEW DETAILS ABOUT SEVERAL PROTEINS IMPLICATED IN CANCER. THE RESEARCH FOCUSED ON THE SMAD4, A TRANSCRIPTION FACTOR THAT NORMALLY SUPPRESSES TUMOR GROWTH, AND A PROTEIN CALLED BRK THAT BINDS TO SMAD4 AND LEADS TO ITS BREAKDOWN. THEIR WORK EXAMINED THE PROTEINS IN HUMAN CELL LINES INCLUDING BREAST CELL CANCER TYPES AND SUGGESTED THAT TREATMENTS TARGETING BRK, WHICH IS PRESENT IN MORE THAN 85 PERCENT OF BREAST CANCER TUMORS, COULD HELP REDUCE OR STOP TUMOR GROWTH. THE STUDY WAS PUBLISHED ONLINE OCTOBER 23, 2019, IN SCIENCE ADVANCES. COMPREHENSIVE LISTS OF 2019 ORIGINAL RESEARCH PAPERS, REVIEWS, COMMENTARIES, CHAPTERS, AND BOOKS ORIGINAL RESEARCH PAPERS |
| 1. EFFICIENT DEPLETION OF RIBOSOMAL RNA FOR SEQUENCING IN | PLANARIANS. KIM IV,ROSS EJ, DIETRICH S, DORING K, SNCHEZ ALVARADO A, KUHN CD. BMC GENOMICS.2019;20:909. DOI: 10.1186/S12864-019-6292-Y. 2. BRK PHOSPHORYLATES SMAD4 FOR PROTEASOMAL DEGRADATION AND INHIBITS TUMOR SUPPRESSOR FRK TO CONTROL SNAIL, SLUG AND METASTATIC POTENTIAL. MIAH S, BANKS CAS,OGUNBOLUDE Y, BAGU ET, BERG JM, SARAF A, TETTEY TT, HATTEM G, DAYEBGADOH G, KEMPF CG, SARDIU M, NAPPER S, FLORENS L, LUKONG KE, WASHBURN MP. SCI ADV.2019;5:EAAW3113. DOI: 3110.1126/SCIADV.AAW3113. 3. PLANARIANS RECRUIT PIRNAS FOR MRNA TURNOVER IN ADULT STEM CELLS. KIM IV, DUNCAN EM, ROSS EJ, GORBOVYTSKA V, NOWOTARSKI SH, ELLIOTT SA, SNCHEZ ALVARADO A, KUHN CD.GENES DEV. 2019;33:1575-1590. 4. AN ADULT BRAIN ATLAS REVEALS BROAD NEUROANATOMICAL CHANGES IN INDEPENDENTLY EVOLVED POPULATIONS OF MEXICAN CAVEFISH. LOOMIS C, PEUSS R, JAGGARD JB, WANG Y,MCKINNEY S, RAFTOPOULOS A, RAFTOPOULOS S, WHU D, GREEN MR, MCGAUGH SE, ROHNER NE, KEENE AC, DUBOUE ER. FRONT NEUROANAT. 2019;13:88. DOI: 10.3389/FNANA.2019.00088. 5. X CHROMOSOME AND AUTOSOMAL RECOMBINATION ARE DIFFERENTIALLY SENSITIVE TO DISRUPTIONS IN SC MAINTENANCE. BILLMYRE KK, CAHOON CK, HEENAN GM, WESLEY ER, YU Z,UNRUH JR, TAKEO S, HAWLEY RS. PROC NATL ACAD SCI U S A. 2019;116:21641-21650. 6. AN ATLAS OF TRANSCRIPTION FACTORS EXPRESSED IN MALE PUPAL TERMINALIA OF DROSOPHILA MELANOGASTER. VINCENT BJ, RICE GR, WONG GM, GLASSFORD WJ, DOWNS KI, SHASTAY JL, CHARLES-OBI K, NATARAJAN M, GOGOL M, ZEITLINGER J, REBEIZ M. G3(BETHESDA). 2019. DOI: 10.1534/G3.119.400788. 7. DEFINING THE EXPRESSION OF PIRNA AND TRANSPOSABLE ELEMENTS IN DROSOPHILA OVARIAN GERMLINE STEM CELLS AND SOMATIC SUPPORT CELLS. STORY B, MA X, ISHIHARA K, LI H, HALL K, PEAK A, ANOJA P, PARK J, HAUG J, BLANCHETTE M, XIE T. LIFE SCI ALLIANCE.2019;2:E201800211. DOI: 10.26508/LSA.XXX-XX-XXXX. 8. EVOLUTIONARY ORIGIN AND NOMENCLATURE OF VERTEBRATE WNT11-FAMILY GENES.POSTLETHWAIT JH, NAVAJAS ACEDO J, PIOTROWSKI T. ZEBRAFISH. 2019;16:469-476. 9. PERTURBED CRANIAL NEURAL CREST CELL DEVELOPMENT IN ASSOCIATION WITH REDUCED SONIC HEDGEHOG SIGNALING UNDERLIES THE PATHOGENESIS OF RETINOIC-ACID-INDUCED CLEFT PALATE. WANG Q, KUROSAKA H, KIKUCHI M, NAKAYA A, TRAINOR PA, YAMASHIRO T. DIS MODEL MECH. 2019;12. 10. EXPERIMENTAL EVOLUTION OF IMMUNOLOGICAL SPECIFICITY. FERRO K, PEUSS R, YANG W,ROSENSTIEL P, SCHULENBURG H, KURTZ J. [PUBLISHED AHEAD OF PRINT SEPTEMBER 23 2019].PNAS. 2019. 11. PROTRUSION MEMBRANE PEARLING EMERGES DURING THREE-DIMENSIONAL CELL DIVISION.CABALLERO D, MENDES PINTO I, RUBINSTEIN B, SAMITIER J. PHYS BIOL. 2019. 12. DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (DNA-PKCS) CONTRIBUTES TO INCORPORATION OF HISTONE VARIANT H2A.Z INTO NUCLEOSOMES. WANG LY, HE YX, LI M,DING J, SUI Y, CONAWAY JW, CONAWAY RC, WANG F, JIN J, CAI Y. PROTEIN CELL. 2019;10:694-699. 13. IDENTIFICATION OF A NUCLEAR LOCALIZATION SIGNAL AND IMPORTIN BETA MEMBERS MEDIATING NUAK1 NUCLEAR IMPORT INHIBITED BY OXIDATIVE STRESS. PALMA M, RIFFO EN,SUGANUMA T, WASHBURN MP, WORKMAN JL, PINCHEIRA R, CASTRO AF. J CELL BIOCHEM.2019;120:16088-16107. 14. CELL-SIZE PLEOMORPHISM DRIVES ABERRANT CLONE DISPERSAL IN PROLIFERATING EPITHELIA. RAMANATHAN SP, KRAJNC M, GIBSON MC. DEV CELL. 2019;51:49-61 E44. 15. PCP AND WNT PATHWAY COMPONENTS ACT IN PARALLEL DURING ZEBRAFISH MECHANOSENSORY HAIR CELL ORIENTATION. NAVAJAS ACEDO J, VOAS MG, ALEXANDER R, WOOLLEY T, UNRUH JR, LI H, MOENS C, PIOTROWSKI T. NAT COMMUN. 2019;10:3993. DOI:3910.1038/S41467-41019-12005-Y. 16. BIOCHEMICAL REDUCTION OF THE TOPOLOGY OF THE DIVERSE WDR76 PROTEIN INTERACTOME.DAYEBGADOH G, SARDIU ME, FLORENS L, WASHBURN MP. J PROTEOME RES. 2019;18:3479-3491. 17. GENERATING TOPOLOGICAL PROTEIN INTERACTION SCORES AND DATA VISUALIZATION WITH TOPS. SARDIU M, FLORENS L, WASHBURN MP. [PUBLISHED AHEAD OF PRINT SEPTEMBER 3 2019]. METHODS. 2019. 18. CLUSTERMAP: COMPARE MULTIPLE SINGLE CELL RNA-SEQ DATASETS ACROSS DIFFERENT EXPERIMENTAL CONDITIONS. GAO X, HU D, GOGOL M, LI H. BIOINFORMATICS. 2019;35:3038-3045. 19. AN ATLAS OF ANTERIOR HOX GENE EXPRESSION IN THE EMBRYONIC SEA LAMPREY HEAD: HOXCODE EVOLUTION IN VERTEBRATES. PARKER HJ, BRONNER ME, KRUMLAUF R. DEV BIOL.2019;453:19-33. 20. STABLE TRANSGENESIS IN ASTYANAX MEXICANUS USING THE TOL2 TRANSPOSASE SYSTEM.STAHL BA, PEUSS R, MCDOLE B, KENZIOR A, JAGGARD JB, GAUDENZ K, KRISHNAN J, MCGAUGH SE, DUBOUE ER, KEENE AC, ROHNER N. DEV DYN. 2019;248:679-687. 21. THE E3 UBIQUITIN LIGASE SPOP CONTROLS RESOLUTION OF SYSTEMIC INFLAMMATION BY TRIGGERING MYD88 DEGRADATION. GUILLAMOT M, OUAZIA D, DOLGALEV I, YEUNG ST,KOURTIS N, DAI Y, CORRIGAN K, ZEA-REDONDO L, SARAF A, FLORENS L, WASHBURN MP,TIKHONOVA AN, MALUMBRES M, GONG Y, TSIRIGOS A, PARK C, BARBIERI C, KHANNA KM,BUSINO L, AIFANTIS I. NAT IMMUNOL. 2019;20:1196-1207. 22. A CONSERVED REGULATORY PROGRAM INITIATES LATERAL PLATE MESODERM EMERGENCE ACROSS CHORDATES. PRUMMEL KD, HESS C, NIEUWENHUIZE S, PARKER HJ, ROGERS KW,KOZMIKOVA I, RACIOPPI C, C. BE, CZARKWIANI A, KNAPP D, BURGER S, CHIAVACCI E, SHAH G,BURGER A, HUISKEN J, YUN M, CHRISTIAEN L, KOZMIK Z, CHRISTIAEN L, MULLER P, BRONNER M,KRUMLAUF R, MOSIMANN C. NAT COMMUN. 2019;10:E3857. DOI: 3810.1038/S41467-41019-11561-41467. 23. MEASURING SIMILARITY BETWEEN GENE INTERACTION PROFILES. BARIDO-SOTTANI J,CHAPMAN SD, KOSMAN E, MUSHEGIAN AR. BMC BIOINFORMATICS. 2019;20:435. DOI:410.1186/S12859-12019-13024-X. 24. COMPARISON OF BLEACHING PROTOCOLS UTILIZING HEMATOXYLIN AND EOSIN STAIN ANDIMMUNOHISTOCHEMICAL PROLIFERATION MARKER MCM3 IN PIGMENTED MELANOMAS. JORDAN T, WILLIAMS D, CRISWELL S, WANG Y. [PUBLISHED AHEAD OF PRINT AUGUST 17 2019].J HISTOTECHNOL. 2019:1-6. 25. ALKALINE PHOSPHATASE-BASED CHROMOGENIC AND FLUORESCENCE DETECTION METHOD FOR BASESCOPE IN SITU HYBRIDIZATION. WANG Y, XU W, MADDERA L, TSUCHIYA D, THOMAS N, YU CR, PARMELY T. [PUBLISHED AUGUST 17 2019]. J HISTOTECHNOL. 2019:1-9. 26. WNT AND TGF-? COORDINATE GROWTH AND PATTERNING TO REGULATE SIZE-DEPENDENT BEHAVIOR. ARNOLD CP, BENHAM-PYLE BW, LANGE JJ, WOOD CJ, SNCHEZ ALVARADO A.NATURE. 2019;572:655-659. 27. DETECTING AND CHARACTERIZING PROTEIN SELF-ASSEMBLY IN VIVO BY FLOW CYTOMETRY.VENKATESAN S, KANDOLA TS, RODRIGUEZ-GAMA A, BOX A, HALFMANN R. J VIS EXP.2019;149:E59577. DOI: 59510.53791/59577. 28. FILLING IN THE PHYLOGENETIC GAPS: INDUCTION, MIGRATION AND DIFFERENTIATION OF NEURAL CREST CELLS IN A SQUAMATE REPTILE, THE VEILED CHAMELEON (CHAMAELEOCALYPTRATUS). DIAZ RE, JR., SHYLO NA, ROELLIG D, BRONNER M, TRAINOR PA. DEV DYN.2019;248:709-727. 29. THE TRANSCRIPTOME OF THE VEILED CHAMELEON (CHAMAELEO CALYPTRATUS): A RESOURCE FOR STUDYING THE EVOLUTION AND DEVELOPMENT OF VERTEBRATES. PINTO BJ, CARD DC, CASTOE TA, DIAZ RE, JR., NIELSEN SV, TRAINOR PA, GAMBLE T. DEV DYN. 2019;248:702-708. 30. RUNX PROTEINS DESENSITIZE MULTIPLE MYELOMA TO LENALIDOMIDE VIA PROTECTING IKZFS FROM DEGRADATION. ZHOU N, GUTIERREZ-UZQUIZA A, ZHENG XY, CHANG R, VOGL DT,GARFALL AL, BERNABEI L, SARAF A, FLORENS L, WASHBURN MP, ILLENDULA A, BUSHWELLER JH,BUSINO L. LEUKEMIA. 2019;33:2006-2021. 31. ATAXIN-7 AND NON-STOP COORDINATE SCAR PROTEIN LEVELS, SUBCELLULAR LOCALIZATION,AND ACTIN CYTOSKELETON ORGANIZATION. CLOUD V, THAPA A, MORALES-SOSA P, MILLER T,MILLER SA, HOLSAPPLE D, GERHART P, MOMTAHAN E, JACK JL, LEIVA E, RAPP SR, SHELTON LG,PIERCE RA, MARTIN-BROWN S, FLORENS L, WASHBURN MP, MOHAN RD. ELIFE. 2019;8. DOI:10.7554/ELIFE.49677. 32. STRUCTURES OF AUTOINHIBITED AND POLYMERIZED FORMS OF CARD9 REVEAL MECHANISMS OF CARD9 AND CARD11 ACTIVATION. HOLLIDAY MJ, WITT A, RODRIGUEZ GAMA A, WALTERS BT,ARTHUR CP, HALFMANN R, ROHOU A, DUEBER EC, FAIRBROTHER WJ. NAT COMMUN.2019;10:3070. DOI: 10.1038/S41467-019-10953-Z. 33. COMPREHENSIVE SINGLE-CELL TRANSCRIPTOME LINEAGES OF A PROTO-VERTEBRATE. CAO C,LEMAIRE LA, WANG W, YOON PH, CHOI YA, PARSONS LR, MATESE JC, WANG W, LEVINE M,CHEN K. NATURE. 2019;571:349-354. |
| 34. AMYLOID-LIKE ASSEMBLY ACTIVATES A PHOSPHATASE IN THE DEVELOPING | DROSOPHILA EMBRYO. NIL Z, MILLAN RH, GERBICH T, LEAL P, YU Z, SARAF A, SARDIU M, LANGE JJ, YI K, UNRUH J, SLAUGHTER B, SI K. CELL. 2019;178:1403-1420 E1421. 35. SUPER-RESOLUTION MICROSCOPY REVEALS LINKAGES BETWEEN RIBOSOMAL DNA ON HETEROLOGOUS CHROMOSOMES. POTAPOVA TA, UNRUH JR, YU Z, RANCATI G, LI H, STAMPFER MR, GERTON JL. J CELL BIOL. 2019;218:2492-2513. 36. SIGNATURES OF DIVERGENCE, INVASIVENESS AND TERRESTRALIZATION REVEALED BY FOUR APPLE SNAIL GENOMES. SUN J, MU H, IP JCH, LI R, XU T, ACCORSI A, SNCHEZ ALVARADO A, ROSS E, LAN Y, SUN Y, CASTRO-VAZQUEZ A, VEGA IA, HERAS H, ITUARTE S, VAN BOCXLAER B, HAYES KA, COWIE RH, ZHAO Z, ZHANG Y, QIAN PY, QIU JW. MOL BIOL EVOL. 2019;36:1507-1520. 37. P53 AND B-CATENIN EXPRESSION PREDICT POORER PROGNOSIS IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA. RICHARDSON AI, YIN CC, CUI W, LI N, MEDEIROS LJ, LI L, ZHANG D. CLIN LYMPHOMA MYELOMA LEUK. 2019;19:E385-E392. DOI: 310.1016/J.CLML.2019.1003.1030. 38. THE STOICHIOMETRY OF THE OUTER KINETOCHORE IS MODULATED BY MICROTUBULE-PROXIMAL REGULATORY FACTORS. DHATCHINAMOORTHY K, UNRUH JR, LANGE JJ, LEVY M, SLAUGHTER BD, GERTON JL. J CELL BIOL. 2019;218:2124-2135. 39. THE EXOCYST FUNCTIONS IN NICHE CELLS TO PROMOTE GERMLINE STEM CELL DIFFERENTIATION BY DIRECTLY CONTROLLING EGFR MEMBRANE TRAFFICKING. MAO Y, TU R, HUANG Y, MAO D, YANG Z, LAU PK, WANG J, NI J, GUO Y, XIE T. DEVELOPMENT. 2019;146:DEV174615 DOI: 174610.171242/DEV.174615. 40. A ROLE FOR FACT IN RNA POLYMERASE II PROMOTER-PROXIMAL PAUSING. TETTEY TT, GAO X, SHAO W, STORY BA, CHITSAZAN AD, GLASER RL, SEIDEL CW, CONAWAY RC, ZEITLINGER J, BLANCHETTE M, CONAWAY JW. CELL REP. 2019;27:3770-3779 E7. 41. JUNCTIONAL TUMOR SUPPRESSORS INTERACT WITH 14-3-3 PROTEINS TO CONTROL PLANAR SPINDLE ALIGNMENT. NAKAJIMA YI, LEE ZT, MCKINNEY SA, SWANSON SK, FLORENS L, GIBSON MC. J CELL BIOL. 2019;218:1824-1838. 42. STRUCTURE AND FUNCTION OF SPC42 COILED-COILS IN YEAST CENTROSOME ASSEMBLY AND DUPLICATION. DRENNAN AC, KRISHNA S, SEEGER MA, ANDREAS MP, GARDNER JM, SETHER EKR, JASPERSEN SL, RAYMENT I. MOL BIOL CELL. 2019;30:1505-1522. 43. KILLER MEIOTIC DRIVE AND DYNAMIC EVOLUTION OF THE WTF GENE FAMILY. EICKBUSH MT, YOUNG JM, ZANDERS SE. MOL BIOL EVOL. 2019;36:1201-1214. 44. GAMETE COLLECTION AND IN VITRO FERTILIZATION OF ASTYANAX MEXICANUS. PEUSS R, ZAKIBE Z, KRISHNAN J, MERRYMAN MS, BAUMANN DP, ROHNER N. J VIS EXP. 2019. DOI: 10.3791/59334. 45. DOWNREGULATION OF FGF SIGNALING BY SPRY4 OVEREXPRESSION LEADS TO SHAPE IMPAIRMENT, ENAMEL IRREGULARITIES, AND DELAYED SIGNALING CENTER FORMATION IN THE MOUSE MOLAR. MARANGONI P, CHARLES C, AHN Y, SEIDEL K, JHEON A, GANSS B, KRUMLAUF R, VIRIOT L, KLEIN OD. JBMR PLUS. 2019;3:E10205. DOI: 10210.11002/JBM10204.10205. 46. THE E3 UBIQUITIN LIGASE SINA REGULATES THE ASSEMBLY AND DISASSEMBLY OF THE SYNAPTONEMAL COMPLEX IN DROSOPHILA FEMALES. HUGHES SE, HEMENWAY E, GUO F, YI K, YU Z, HAWLEY RS. PLOS GENET. 2019;15:E1008161. DOI: 10.1371/JOURNAL.PGEN.1008161. 47. ARTIFICIAL RNA POLYMERASE II ELONGATION COMPLEXES FOR DISSECTING CO-TRANSCRIPTIONAL RNA PROCESSING EVENTS. NOE GONZALEZ M, CONAWAY JW, CONAWAY RC. J VIS EXP. 2019;147: DOI: 10.3791/59497. 48. HYPO-OSMOTIC-LIKE STRESS UNDERLIES GENERAL CELLULAR DEFECTS OF ANEUPLOIDY. TSAI HJ, NELLIAT AR, CHOUDHURY MI, KUCHARAVY A, BRADFORD WD, COOK ME, KIM J, MAIR DB, SUN SX, SCHATZ MC, LI R. NATURE. 2019;570:117-121. 49. YEAST CENTROSOME COMPONENTS FORM A NONCANONICAL LINC COMPLEX AT THE NUCLEAR ENVELOPE INSERTION SITE. CHEN J, GARDNER JM, YU Z, SMITH SE, MCKINNEY S, SLAUGHTER BD, UNRUH JR, JASPERSEN SL. J CELL BIOL. 2019;218:1478-1490. 50. DOPAMINE RECEPTOR ANTAGONISTS AS POTENTIAL THERAPEUTIC AGENTS FOR ADPKD. PAUL P, RAMACHANDRAN S, XIA S, UNRUH JR, CONKRIGHT-FINCHAM J, LI R. PLOS ONE. 2019;14:E0216220. DOI: 10.1371/JOURNAL.PONE.0216220. 51. REPORTER-CHIP-NEXUS REVEALS STRONG CONTRIBUTION OF THE DROSOPHILA INITIATOR SEQUENCE TO RNA POLYMERASE PAUSING. SHAO W, ALCANTARA SG, ZEITLINGER J. ELIFE. 2019;8:E41461. DOI: 41410.47554/ELIFE.41461. 52. TRANSLATION AFFECTS MRNA STABILITY IN A CODON-DEPENDENT MANNER IN HUMAN CELLS. WU Q, MEDINA SG, KUSHAWAH G, DEVORE ML, CASTELLANO LA, HAND JM, WRIGHT M, BAZZINI AA. ELIFE. 2019;8:E45396. DOI: 45310.47554/ELIFE.45396. 53. SET1-CATALYZED H3K4 TRIMETHYLATION ANTAGONIZES THE HIR/ASF1/RTT106 REPRESSOR COMPLEX TO PROMOTE HISTONE GENE EXPRESSION AND CHRONOLOGICAL LIFE SPAN. MEI Q, XU C, GOGOL M, TANG J, CHEN W, YU X, WORKMAN JL, LI S. NUCLEIC ACIDS RES. 2019;47:3434-3449. 54. EVALUATING CHROMATOGRAPHIC APPROACHES FOR THE QUANTITATIVE ANALYSIS OF A HUMAN PROTEOME ON ORBITRAP-BASED MASS SPECTROMETRY SYSTEMS. ZHANG Y, WEN Z, WASHBURN MP, FLORENS L. J PROTEOME RES. 2019;18:1857-1869. 55. DISTRIBUTION OF PROTEINS AT THE INNER NUCLEAR MEMBRANE IS REGULATED BY THE ASI1 E3 LIGASE IN SACCHAROMYCES CEREVISIAE. SMOYER CJ, SMITH SE, GARDNER JM, MCCROSKEY S, UNRUH JR, JASPERSEN SL. GENETICS. 2019;211:1269-1282. 56. DYRK1A REGULATES THE RECRUITMENT OF 53BP1 TO THE SITES OF DNA DAMAGE IN PART THROUGH INTERACTION WITH RNF169. MENON VR, ANANTHAPADMANABHAN V, SWANSON S, SAINI S, SESAY F, YAKOVLEV V, FLORENS L, DECAPRIO JA, WASHBURN MP, DOZMOROV M, LITOVCHICK L. CELL CYCLE. 2019;18:531-551. 57. A HOX-TALE REGULATORY CIRCUIT FOR NEURAL CREST PATTERNING IS CONSERVED ACROSS VERTEBRATES. PARKER HJ, DE KUMAR B, GREEN SA, PRUMMEL KD, HESS C, KAUFMAN CK, MOSIMANN C, WIEDEMANN LM, BRONNER ME, KRUMLAUF R. NAT COMMUN. 2019;10:1189. DOI: 1110.1038/S41467-41019-09197-41468. 58. TOPOLOGICAL SCORING OF PROTEIN INTERACTION NETWORKS. SARDIU ME, GILMORE JM, GROPPE BD, DUTTA A, FLORENS L, WASHBURN MP. NAT COMMUN. 2019;10:1118. DOI: 1110.1038/S41467-41019-09123-Y. 59. IMAGING-BASED ASSAYS FOR INVESTIGATING FUNCTIONS OF THE RNA POLYMERASE II ELONGATION FACTOR ELONGIN AND THE ELONGIN UBIQUITIN LIGASE. WEEMS JC, UNRUH JR, SLAUGHTER BD, CONAWAY RC, CONAWAY JW. METHODS. 2019;159-160:157-164. 60. CHARACTERIZATION OF A METAZOAN ADA ACETYLTRANSFERASE COMPLEX. SOFFERS JHM, LI X, SARAF A, SEIDEL CW, FLORENS L, WASHBURN MP, ABMAYR SM, WORKMAN JL. NUCLEIC ACIDS RES. 2019;47:3383-3394. 61. A CHEMOPROTEOMIC PORTRAIT OF THE ONCOMETABOLITE FUMARATE. KULKARNI RA, BAK DW, WEI D, BERGHOLTZ SE, BRINEY CA, SHRIMP JH, ALPSOY A, THORPE AL, BAVARI AE, CROOKS DR, LEVY M, FLORENS L, WASHBURN MP, FRIZZELL N, DYKHUIZEN EC, WEERAPANA E, LINEHAN WM, MEIER JL. NAT CHEM BIOL. 2019;15:391-400 62. HOST VESICLE FUSION PROTEIN VAPB IS REQUIRED FOR THE NUCLEAR EGRESS STAGE OF HERPES SIMPLEX VIRUS TYPE-1 (HSV-1) REPLICATION. SAIZ-ROS N, CZAPIEWSKI R, EPIFANO I, STEVENSON A, SWANSON SK, DIXON CR, ZAMORA DB, MCELWEE M, VIJAYAKRISHNAN S, RICHARDSON CA, DONG L, KELLY DA, PYTOWSKI L, GOLDBERG MW, FLORENS L, GRAHAM SV, SCHIRMER EC. CELLS. 2019;8 E120. DOI: 110.3390/CELLS8020120. 63. TOWARDS THE MOLECULAR DECIPHERING OF POMACEA CANALICULATA IMMUNITY: FIRST PROTEOMIC ANALYSIS OF CIRCULATING HEMOCYTES. BORALDI F, LOFARO FD, ACCORSI A, ROSS E, MALAGOLI D. PROTEOMICS. 2019;19:E1800314. DOI: 1800310.1801002/PMIC.XXX-XX-XXXX. 64. DEFINING GENE NETWORKS CONTROLLING THE MAINTENANCE AND FUNCTION OF THE DIFFERENTIATION NICHE BY AN IN VIVO SYSTEMATIC RNAI SCREEN. GAO Y, MAO Y, XU RG, ZHU R, ZHANG M, SUN J, SHEN D, PENG P, XIE T, NI JQ. J GENET GENOME. 2019;46:19-30. 65. SCRNA-SEQ REVEALS DISTINCT STEM CELL POPULATIONS THAT DRIVE HAIR CELL REGENERATION AFTER LOSS OF FGF AND NOTCH SIGNALING. LUSH ME, DIAZ DC, KOENECKE N, BAEK S, BOLDT H, ST PETER MK, GAITAN-ESCUDERO T, ROMERO-CARVAJAL A, BUSCH-NENTWICH EM, PERERA AG, HALL KE, PEAK A, HAUG JS, PIOTROWSKI T. ELIFE. 2019;8:E44431. DOI: 44410.47554/ELIFE.44431. 66. N-CADHERIN-EXPRESSING BONE AND MARROW STROMAL PROGENITOR CELLS MAINTAIN RESERVE HEMATOPOIETIC STEM CELLS. ZHAO M, TAO F, VENKATRAMAN A, LI Z, SMITH SE, UNRUH J, CHEN S, WARD C, QIAN P, PERRY JM, MARSHALL H, WANG J, HE XC, LI L. CELL REP. 2019;26:652-669 E656. 67. THE DROSOPHILA DBF4 ORTHOLOG CHIFFON FORMS A COMPLEX WITH GCN5 THAT IS NECESSARY FOR HISTONE ACETYLATION AND VIABILITY. TORRES-ZELADA EF, STEPHENSON RE, ALPSOY A, ANDERSON BD, SWANSON SK, FLORENS L, DYKHUIZEN EC, WASHBURN MP, WEAKE VM. J CELL SCI. 2019;132:JCS.214072. 68. ELECTROPORATION OF SHORT HAIRPIN RNAS FOR RAPID AND EFFICIENT GENE KNOCKDOWN IN THE STARLET SEA ANEMONE, NEMATOSTELLA VECTENSIS. KARABULUT A, HE S, CHEN CY, MCKINNEY SA, GIBSON MC. DEV BIOL. 2019;448:7-15. 69. OOCYTE-SPECIFIC DELETION OF HDAC8 IN MICE REVEALS STAGE-SPECIFIC EFFECTS ON FERTILITY. SINGH VP, YUEH WT, GERTON JL, DUNCAN FE. REPRODUCTION. 2019;157:305-316. 70. NARYA, A RING FINGER DOMAIN-CONTAINING PROTEIN, IS REQUIRED FOR BOTH MEIOTIC DNA DOUBLE-STRAND BREAK FORMATION AND CROSSOVER MATURATION IN DROSOPHILA MELANOGASTER. LAKE CM, NIELSEN RJ, BONNER AM, ECHE S, WHITE-BROWN S, MCKIM KS, HAWLEY RS. PLOS GENET. 2019;15:E1007886. DOI:1007810.1001371/JOURNAL.PGEN.1007886. |
| 71. SHH PLAYS AN INHIBITORY ROLE IN CUSP PATTERNING BY REGULATION OF | SOSTDC1. KIM J, AHN Y, ADASOORIYA D, WOO EJ, KIM HJ, HU KS, KRUMLAUF R, CHO SW. J DENT RES. 2019;98:98-106. 72. FUNCTIONAL CONSEQUENCES OF THE EVOLUTION OF MATRIMONY, A MEIOSIS-SPECIFIC INHIBITOR OF POLO KINASE. BONNER AM, HAWLEY RS. MOL BIOL EVOL. 2019;36:69-83. 73. GLYCOLYSIS REGULATES GENE EXPRESSION BY PROMOTING THE CROSSTALK BETWEEN H3K4 TRIMETHYLATION AND H3K14 ACETYLATION IN SACCHAROMYCES CERVISIAE. WU Y, ZHANG S, GONG X, YU Q, ZHANG Y, LUO M, ZHANG X, WORMAN JL, YU X, LI S. J GENET GENOMICS. 2019;46:561-574. 74. UNIDIRECTIONAL PROPULSION OF PLANAR MAGNETIC NANOMACHINES. COHEN K-J, RUBINSTEIN BY, KENNETH O, LESHANSKY AM. PHYS REV APPLIED. 2019;12:014025:1-10. REVIEWS, COMMENTARIES, CHAPTERS, AND BOOKS 1. CONTINUING THE ADVANCEMENT OF JOURNAL OF HISTOTECHNOLOGY - ONE ISSUE AT A TIME. WANG Y. J HISTOTECHNOL. 2019;42:165-166. 2. EXOGENOUS PYRUVATE REPRESSES HISTONE GENE EXPRESSION AND INHIBITS CANCER CELL PROLIFERATION VIA THE NAMPT-NAD+-SIRT1 PATHWAY. MA R, WU Y, ZHAI Y, HU B, MA W, YANG W, YU Q, CHEN Z, WORKMAN JL, YU X, LI S. NUCLEIC ACIDS RES. 2019;47:11132-11150. 3. THE JOY OF BALANCERS. MILLER DE, COOK KR, HAWLEY RS. PLOS GENET. 2019;15:E1008421. DOI: 1008410.1001371/JOURNAL.PGEN.1008421. 4. REBOOTING THE EPIGENOME: ERASURE OF PARENTAL HISTONE MARKS FOR ESTABLISHING THE REGULATORY LANDSCAPE IN ZYGOTES. BHATTACHARYA S, WORKMAN JL. [PUBLISHED AHEAD OF PRINT OCTOBER 23 2019]. BIOCHEMISTRY. 2019. 5. BEYOND BASIC AT THE STOWERS INSTITUTE FOR MEDICAL RESEARCH. BLAND K, ORR AA. MO MED. 2019;116:457-460. 6. AN INTERDISCIPLINARY APPROACH TO INVESTIGATE COLLECTIVE CELL MIGRATION IN NEURAL CREST. GINIUNAITE R, MCLENNAN R, MCKINNEY MC, BAKER RE, KULESA PM, MAINI PK. [PUBLISHED AHEAD OF PRINT OCTOBER 18 2019]. DEV DYN. 2019. 7. PURIFICATION AND ENZYMATIC ASSAY OF CLASS I HISTONE DEACETYLASE ENZYMES. ADAMS MK, BANKS CAS, MIAH S, KILLER M, WASHBURN MP. METHODS ENZYMOL. 2019;626:23-40. 8. COMPARING SENSORY ORGANS TO DEFINE THE PATH FOR HAIR CELL REGENERATION. DENANS N, BAEK S, PIOTROWSKI T. ANNU REV CELL DEV BIOL. 2019;35:568-589. 9. NSL COMPLEX ACETYLATES LAMIN A/C. POPOVA VV, WORKMAN JL. NAT CELL BIOL. 2019;21:1177-1178. 10. PATROLLING THE NUCLEUS: INNER NUCLEAR MEMBRANE-ASSOCIATED DEGRADATION. SMOYER CJ, JASPERSEN SL. CURR GENET. 2019;65:1099-1106. 11. THE HUNT FOR RNA POLYMERASE II ELONGATION FACTORS: A HISTORICAL PERSPECTIVE. CONAWAY RC, CONAWAY JW. NAT STRUCT MOL BIOL. 2019;26:771-776. 12. REGULATION OF GENOMIC OUTPUT AND (PLURI)POTENCY IN REGENERATION. DUNCAN EM, SNCHEZ ALVARADO A. ANNU REV GENET. 2019;53:16.1-16.20. 13. CNIDOFEST 2018: THE FUTURE IS BRIGHT FOR CNIDARIAN RESEARCH. HE S, GRASIS JA, NICOTRA ML, JULIANO CE, SCHNITZLER CE. EVODEVO. 2019;10:20. DOI: 10.1186/S13227-13019-10134-13225. 14. HISTONE LYSINE DE-BETA-HYDROXYBUTYRYLATION BY SIRT3. ABMAYR SM, WORKMAN JL. CELL RES. 2019;29:694-695. 15. GENE CONVERSION GENERATES EVOLUTIONARY NOVELTY THAT FUELS GENETIC CONFLICTS. DAUGHERTY MD, ZANDERS SE. V.CURR OPIN GENET DE 2019;58:49-54. 16. A FAMILY OF KILLERS. DE CARVALHO M, ZANDERS SE. ELIFE. 2019;8:E46454. DOI: 46410.47554/ELIFE.46454. 17. WHEN MOTHERS LEAVE THEIR MARK. BARAJAS-AZPELETA R, SI K. ELIFE. 2019;8:E48899. DOI:48810.47554/ELIFE.48899. 18. HEMATOPOIETIC STEM CELLS: SELF-RENEWAL AND EXPANSION. LI Z, HE XC, LI L. CURR OPIN HEMATOL. 2019;26:258-265. 19. FERTILITY COSTS OF MEIOTIC DRIVERS. ZANDERS SE, UNCKLESS RL. CURR BIOL. 2019;29:R512-R520. 20. CORNELIA DE LANGE SYNDROME, RELATED DISORDERS, AND THE COHESIN COMPLEX: ABSTRACTS FROM THE 8TH BIENNIAL SCIENTIFIC AND EDUCATIONAL SYMPOSIUM 2018. KLINE AD, KRANTZ ID, BANDO M, SHIRAHIGE K, CHEA S, SAKATA T, RAO S, DORSETT D, SINGH VP, GERTON JL, HORSFIELD JA, CALOF AL, KATZ O, GRADOS M, RAIBLE S, BARANANO K, LYON G, MUSIO A, CARRICO CS, CLEMENS DK, CAUDILL P, MASSA V, MCGILL BE, DOMMESTRUP A, O'CONNOR J, HAALAND RE. AM J MED GENET A. 2019;179:1030-1090. 21. HOX GENES: DOWNSTREAM "EFFECTORS" OF RETINOIC ACID SIGNALING IN VERTEBRATE EMBRYOGENESIS. NOLTE C, DE KUMAR B, KRUMLAUF R. GENESIS. 2019:E23306. DOI:10.1002/DVG.23306. 22. NICHE CELLS REWIRED TO MAINTAIN HSCS EX VIVO. VENKATRAMAN A, LI L. NAT CELL BIOL. 2019;21:540-541. 23. COMMENTARY ON "REGENERATION, DUPLICATION AND TRANSDETERMINATION IN FRAGMENTS OF THE LEG DISC OF DROSOPHILA MELANOGASTER": SCHUBIGER, G. (1971). DEV BIOL. 2019;449:63-82.. GIBSON MC. DEV BIOL. 2019;449:63-82. 24. IN OVO ELECTROPORATION OF PLASMID DNA AND MORPHOLINOS INTO SPECIFIC TISSUES DURING EARLY EMBRYOGENESIS. MCLENNAN R, KULESA PM. METHODS MOL BIOL.2019;1976:71-82. 25. MOUSE EMBRYO CULTURE FOR THE STUDY OF NEURAL CREST CELLS. MUNOZ WA, TRAINOR PA. METHODS MOL BIOL: MEIOSIS. 2019;1976:107-119. 26. OBSERVATION OF TWO SEPARATE BIPOLAR SPINDLES IN THE HUMAN ZYGOTE. XU, X., LI L, ZHANG C, MENG L. J ASSIST REPROD GENET. 2019;36:601-602. CORRECTION: J ASSIST REPROD GENET. 2019 JUL 31. PII: 10.1007/S10815-019-01539-1. DOI: 10.1007/S10815-019-01539-1. 27. SWEET FISH: FISH MODELS FOR THE STUDY OF HYPERGLYCEMIA AND DIABETES. KRISHNAN J, ROHNER N. J DIABETES. 2019;11:193-203. 28. RIBOSOMAL DNA INSTABILITY AND GENOME ADAPTABILITY. SALIM D, GERTON JL. CHROMOSOME RES. 2019;27:73-87. 29. RIBOSOMAL DNA AND THE NUCLEOLUS IN THE CONTEXT OF GENOME ORGANIZATION. POTAPOVA TA, GERTON JL. CHROMOSOME RES. 2019;27:109-127. 30. THE SOCIETY FOR CRANIOFACIAL GENETICS AND DEVELOPMENTAL BIOLOGY 41ST ANNUAL MEETING. TANEYHILL LA, MOODY SA, COX T, KLEIN OD, MARCUCIO R, SCHNEIDER RA, TRAINOR PA. AM J MED GENET A. 2019;179:864-869. 31. MANIPULATION OF DEVELOPMENTAL FUNCTION IN TURTLES WITH NOTES ON ALLIGATORS. MOUSTAKAS-VERHO JE, MCLENNAN R, SPENGLER J, KULESA PM, CEBRA-THOMAS JA. METHODS MOL BIOL. 2019;1920:247-263. AUTHOR'S CORRECTION: METHODS MOL BIOL. 2019;1920:C1. 32. AN INTEGRATIVE VIEW OF LEPIDOSAUR CRANIAL ANATOMY, DEVELOPMENT AND DIVERSIFICATION. DIAZ JR. RE, TRAINOR PA. IN: ZIERMANN, D JR., AND DIOGO, EDS. HEADS, JAWS AND MUSCLES ANATOMICAL, FUNCTIONAL AND DEVELOPMENTAL DIVERSITY IN CHORDATE EVOLUTION, SPRINGER; 2019:207-227. 33. RIBOSOMAL DNA-CONNECTING RIBOSOME BIOGENESIS AND CHROMOSOME BIOLOGY. POROKHOVNIK L, GERTON JL. CHROMOSOME RES. 2019;27:1-3. 34. RECENT ADVANCES IN UNDERSTANDING INTESTINAL STEM CELL REGULATION. HU D, YAN H, HE XC, LI L. F1000RES. 2019;8:F1000 FACULTY REV-72. PUBLISHED 2019 JAN 18. DOI:10.12688/F1000RESEARCH.16793.1 COMPETITIVE RESEARCH GRANT FUNDING & RESEARCH AWARDS & DISTINCTIONS THE ABILITY OF SIMR SCIENTISTS TO RECEIVE COMPETITIVELY AWARDED RESEARCH FUNDING ATTESTS TO THE HIGH LEVEL OF RESEARCH PRODUCTIVITY PRESENT AT SIMR. DURING 2019, SIMR SCIENTISTS WORKED WITH THE SUPPORT OF 31 GRANTS AND FELLOWSHIPS FROM THE NATIONAL INSTITUTES OF HEALTH, TWO GRANTS FROM THE NATIONAL SCIENCE FOUNDATION, TWO GRANTS FROM THE MARCH OF DIMES, ONE GRANT FROM THE GREATER KANSAS CITY COMMUNITY FOUNDATION, ONE GRANT FROM THE HEARING HEALTH FOUNDATION, ONE FELLOWSHIP FROM THE JANE COFFIN CHILDS MEMORIAL FUND, ONE AWARD FROM THE SEARLE SCHOLARS PROGRAM, ONE AWARD FROM THE PEW CHARITABLE TRUSTS, ONE AWARD FROM THE UNIVERSITY OF KANSAS ENDOWMENT ASSOCIATION, ONE GRANT FROM THE EDWARD MALLINCKRODT JR. FOUNDATION, ONE GRANT FROM THE JUVENILE DIABETES RESEARCH FOUNDATION, ONE GRANT FROM THE UNIVERSITY OF KANSAS ALZHEIMER'S DISEASE CENTER, ONE GRANT FROM THE UNIVERSITY OF KANSAS CANCER CENTER, AND ONE INVESTIGATOR AWARD FROM THE HOWARD HUGHES MEDICAL INSTITUTE. SUPPORT FROM NEW AND CONTINUING AWARDS TO SIMR TOTALED MORE THAN $6.2 MILLION IN 2019 TO SUPPLEMENT INCOME FROM ITS ENDOWMENTS. TESTIFYING TO THE HIGH LEVEL OF ACHIEVEMENT TAKING PLACE AT SIMR ARE THE AWARDS AND HONORS SIMR MEMBERS RECEIVED IN 2019: 1. NICOLAS ROHNER, PHD, RECEIVED A TWO-YEAR GRANT FROM THE JUVENILE DIABETES RESEARCH FOUNDATION 2. TING XIE, PHD, WAS AWARDED A FIVE-YEAR GRANT FROM THE NIH EUNICE SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT 3. LINHENG LI, PHD, RECEIVED A FIVE-YEAR GRANT FROM THE NIH NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES 4. ARIEL BAZZINI, PHD, RECEIVED A TWO-YEAR PEW INNOVATION FUND AWARD ALONG WITH COLLABORATOR DIEGO ALVAREZ, PHD, FROM THE NATIONAL UNIVERSITY OF SAN MARTIN, ARGENTINA 5. RANDAL HALFMANN, PHD, RECEIVED A FOUR-YEAR NIH GRANT FROM THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 6. ERIC HILL, PHD, A POSTDOCTORAL RESEARCHER IN THE GIBSON LAB, WAS AWARDED A TWOYEAR NIH FELLOWSHIP FROM THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 7. CASSANDRA KEMPF, A PREDOCTORAL RESEARCHER OF THE GRADUATE SCHOOL OF THE STOWERS INSTITUTE, RECEIVED A THREE-YEAR FELLOWSHIP FROM THE NIH NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 8. STACEY HANLON, PHD, A POSTDOCTORAL RESEARCHER IN THE HAWLEY LAB, WAS AWARDED A TWO-YEAR GRANT FROM THE NIH EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT 9. JOSEPH VARBERG, PHD, A POSTDOCTORAL RESEARCHER IN THE JASPERSEN LAB, RECEIVED A ONE-YEAR NIH NRSA POSTDOCTORAL FELLOWSHIP |
| 10. JIANZHENG WU, A UNIVERSITY OF KANSAS MEDICAL CENTER PREDOCTORAL | RESEARCHER IN THE HALFMANN LAB, WAS AWARDED A ONE-YEAR FELLOWSHIP FROM THE UNIVERSITY OF KANSAS MEDICAL CENTER INSTITUTE FOR NEUROLOGICAL DISCOVERIES INDEPENDENT RESEARCH PROGRAM LEADERS LABORATORIES INDIVIDUAL SCIENTISTS AT THE SIMR SPECIALIZE IN THE STUDY OF ONE OR MORE PARTICULAR GENES, PROTEINS, OR OTHER MOLECULES, EACH OF WHICH MAY CAUSE OR INFLUENCE VARIOUS KINDS OF DISEASE. A COMPREHENSIVE LIST OF RESEARCH LEADERS FOLLOWS: 1. ALEJANDRO SNCHEZ ALVARADO, PHD, SCIENTIFIC DIRECTOR, INVESTIGATOR, AND HOWARD HUGHES MEDICAL INSTITUTE INVESTIGATOR, JOINED SIMR IN 2011 FROM THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE, WHERE HE HELD THE H.A. & EDNA BENNING PROFESSORSHIP OF NEUROBIOLOGY AND ANATOMY. HE RECEIVED A BS IN MOLECULAR BIOLOGY AND CHEMISTRY FROM VANDERBILT UNIVERSITY IN NASHVILLE, TENN., AND A PHD IN PHARMACOLOGY AND CELL BIOPHYSICS FROM THE UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE IN CINCINNATI, OHIO. RESEARCH FOCUS: THE MOLECULAR AND CELLULAR MECHANISMS UNDERPINNING ANIMAL REGENERATION USING THE PLANARIAN SCHMIDTEA MEDITERRANEA AS A MODEL SYSTEM. 2. ARIEL BAZZINI, PHD, ASSISTANT INVESTIGATOR, JOINED SIMR IN 2016 FROM THE LAB OF ANTONIO J. GIRALDEZ, PHD, IN THE DEPARTMENT OF GENETICS AT YALE UNIVERSITY, WHERE HE COMPLETED A POSTDOCTORAL FELLOWSHIP. DR. BAZZINI RECEIVED HIS PHD IN MOLECULAR BIOLOGY AT THE UNIVERSITY OF BUENOS AIRES, ARGENTINA. FOR HIS DOCTORAL DISSERTATION, HE STUDIED PLANT GENETICS AT THE INSTITUTE OF BIOTECHNOLOGY IN ARGENTINA'S NATIONAL INSTITUTE OF AGRICULTURAL TECHNOLOGY (INTA). RESEARCH FOCUS: THE REGULATION OF GENE EXPRESSION IN VERTEBRATES. 3. JOAN CONAWAY, PHD, INVESTIGATOR, JOINED SIMR IN 2001 FROM THE OKLAHOMA MEDICAL RESEARCH FOUNDATION WHERE SHE WAS AN ASSOCIATE INVESTIGATOR OF THE HOWARD HUGHES MEDICAL INSTITUTE AND INTERIM HEAD OF THE PROGRAM IN MOLECULAR AND CELL BIOLOGY. DR. CONAWAY RECEIVED HER DOCTORATE IN CELL BIOLOGY FROM STANFORD UNIVERSITY SCHOOL OF MEDICINE. RESEARCH FOCUS: ANALYSIS OF THE MOLECULAR MECHANISM AND REGULATION OF GENE TRANSCRIPTION. 4. RONALD CONAWAY, PHD, INVESTIGATOR, JOINED SIMR IN 2001 FROM THE OKLAHOMA MEDICAL RESEARCH FOUNDATION WHERE HE WAS HOLDER OF THE CHAPMAN CHAIR IN MEDICAL RESEARCH. DR. CONAWAY RECEIVED HIS PHD IN BIOCHEMISTRY FROM STANFORD UNIVERSITY SCHOOL OF MEDICINE. RESEARCH FOCUS: ANALYSIS OF THE MOLECULAR MECHANISM AND REGULATION OF GENE TRANSCRIPTION. 5. JENNIFER GERTON, PHD, INVESTIGATOR, JOINED SIMR IN 2002 FROM A POSTDOCTORAL FELLOWSHIP IN THE LABORATORY OF DR. JOSEPH DERISI IN THE DEPARTMENT OF BIOCHEMISTRY AND BIOPHYSICS AT THE UNIVERSITY OF CALIFORNIA-SAN FRANCISCO. DR. GERTON RECEIVED A PHD IN MICROBIOLOGY AND IMMUNOLOGY FROM STANFORD UNIVERSITY. RESEARCH FOCUS: GENOMIC AND GENETIC ANALYSIS OF CHROMOSOME SEGREGATION AND CHROMOSOME DYNAMICS. 6. MATTHEW GIBSON, PHD, INVESTIGATOR AND DEAN OF THE GRADUATE SCHOOL, JOINED SIMR IN 2006 FROM A JANE COFFIN CHILDS MEMORIAL FUND POSTDOCTORAL FELLOWSHIP WITH DR. NORBERT PERRIMON AT HARVARD MEDICAL SCHOOL. DR. GIBSON RECEIVED A PHD IN ZOOLOGY FROM THE UNIVERSITY OF WASHINGTON. RESEARCH FOCUS: GENETIC ANALYSIS OF MECHANISMS CONTROLLING SIGNAL TRANSDUCTION, CELL PROLIFERATION, AND EPITHELIAL MORPHOGENESIS DURING DROSOPHILA DEVELOPMENT. 7. RANDAL HALFMANN, PHD, ASSISTANT INVESTIGATOR, JOINED SIMR IN 2015 FROM THE UNIVERSITY OF TEXAS (UT) SOUTHWESTERN MEDICAL CENTER. HE RECEIVED A PHD IN BIOLOGY FROM THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WHERE HE WAS A NATIONAL SCIENCE FOUNDATION PREDOCTORAL FELLOW. AFTER COMPLETING HIS GRADUATE STUDIES, DR. HALFMANN OBTAINED AN INDEPENDENT POSITION AT UT SOUTHWESTERN MEDICAL CENTER WHERE HE WAS A SARA AND FRANK MCKNIGHT FELLOW AND RECEIVED A DIRECTOR'S EARLY INDEPENDENCE AWARD FROM THE NATIONAL INSTITUTES OF HEALTH. RESEARCH FOCUS: CELLULAR AND EVOLUTIONARY IMPLICATIONS OF PROTEIN SELF-ASSEMBLY USING GENETIC, BIOCHEMICAL, AND CELL-BIOLOGICAL APPROACHES. 8. R. SCOTT HAWLEY, PHD, INVESTIGATOR AND DEAN EMERITUS OF THE GRADUATE SCHOOL, JOINED SIMR IN 2001 FROM THE UNIVERSITY OF CALIFORNIA-DAVIS WHERE HE WAS A PROFESSOR OF GENETICS IN THE MOLECULAR AND CELLULAR BIOLOGY SECTION. DR. HAWLEY EARNED A PHD IN GENETICS FROM THE UNIVERSITY OF WASHINGTON AND COMPLETED POSTDOCTORAL TRAINING AS A HELEN HAY WHITNEY FELLOW AT THE INSTITUTE FOR CANCER RESEARCH IN PHILADELPHIA. RESEARCH FOCUS: INVESTIGATION OF MECHANISMS THAT INFLUENCE HOW CHROMOSOMES PAIR AND SEGREGATE DURING MEIOSIS USING DROSOPHILA AS AN EXPERIMENTAL SYSTEM. 9. SUE JASPERSEN, PHD, ASSOCIATE INVESTIGATOR, JOINED SIMR IN 2005 FROM THE LABORATORY OF DR. MARK WINEY AT THE UNIVERSITY OF COLORADO-BOULDER WHERE SHE WAS A KECK FOUNDATION FELLOW, A HELEN HAY WHITNEY FELLOW, AND THE RECIPIENT OF A LEUKEMIA & LYMPHOMA SOCIETY CAREER DEVELOPMENT AWARD. DR. JASPERSEN HOLDS A PHD IN BIOCHEMISTRY FROM THE UNIVERSITY OF CALIFORNIA-SAN FRANCISCO. RESEARCH FOCUS: INNER NUCLEAR MEMBRANE PROTEIN LOCALIZATION AND ROLE IN CHROMOSOME POSITIONING AND SEGREGATION. 10. ROBERT KRUMLAUF, PHD, SCIENTIFIC DIRECTOR EMERITUS AND INVESTIGATOR, JOINED THE SIMR IN 2000 FROM ENGLAND'S NATIONAL INSTITUTE FOR MEDICAL RESEARCH, THE RIDGEWAY, MILL HILL, LONDON, WHERE HE WAS HEAD OF THE DIVISION OF DEVELOPMENTAL NEUROBIOLOGY. DR. KRUMLAUF RECEIVED A PHD IN DEVELOPMENTAL BIOLOGY FROM OHIO STATE UNIVERSITY. RESEARCH FOCUS: ANALYSIS OF MOLECULAR PATHWAYS THAT REGULATE HOW THE MAMMALIAN HEAD, BRAIN AND NERVOUS SYSTEM ARE BUILT, USING A VARIETY OF VERTEBRATE MODEL SYSTEMS. 11. LINHENG LI, PHD, INVESTIGATOR, JOINED SIMR IN 2000 FROM THE UNIVERSITY OF WASHINGTON MEDICAL CENTER WHERE HE HELD A FACULTY APPOINTMENT AFTER COMPLETING POSTDOCTORAL TRAINING IN THE LABORATORY DIRECTED BY DR. LEROY HOOD. DR. LI EARNED HIS PHD IN MOLECULAR AND CELLULAR BIOLOGY FROM NEW YORK UNIVERSITY MEDICAL SCHOOL UNDER THE MENTORING OF DR. EDWARD ZIFF. RESEARCH FOCUS: INVESTIGATION OF MOLECULAR AND GENETIC PATHWAYS CONTROLLING ADULT STEM CELL DEVELOPMENT IN THE HEMATOPOIETIC AND INTESTINAL SYSTEMS USING TRANSGENIC AND GENE TARGETING ANIMAL MODEL APPROACHES. 12. TATJANA PIOTROWSKI, PHD, INVESTIGATOR, JOINED SIMR IN 2011 FROM THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE, WHERE SHE WAS AN ASSOCIATE PROFESSOR IN THE DEPARTMENT OF NEUROBIOLOGY AND ANATOMY. SHE RECEIVED HER MASTER'S DEGREE FROM THE UNIVERSITY OF TUBINGEN, GERMANY, AND HER DOCTORATE DEGREE FROM THE MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY IN TUBINGEN. RESEARCH FOCUS: COLLECTIVE CELL MIGRATION, CELL TYPE SPECIFICATION AND STEM CELL BIOLOGY IN ZEBRAFISH AS A MODEL SYSTEM. 13. NICOLAS ROHNER, PHD, ASSISTANT INVESTIGATOR, JOINED SIMR IN 2015 FROM HARVARD MEDICAL SCHOOL, WHERE HE WAS A POSTDOCTORAL FELLOW IN DR. CLIFF TABIN'S LABORATORY. HE EARNED A PHD IN BIOLOGY FROM THE MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY IN TUBINGEN, GERMANY. RESEARCH FOCUS: GENETIC MECHANISMS AND MUTATIONS THAT UNDERLIE THE ANIMAL KINGDOM'S TREMENDOUS DIVERSITY IN MORPHOLOGY, PHYSIOLOGY, AND BEHAVIOR. 14. KAUSIK SI, PHD, ASSOCIATE SCIENTIFIC DIRECTOR AND INVESTIGATOR, JOINED SIMR IN 2005FROM THE LABORATORY OF DR. ERIC KANDEL AT COLUMBIA UNIVERSITY CENTER FOR NEUROBIOLOGY AND BEHAVIOR WHERE HE WAS A JANE COFFIN CHILDS FELLOW AND A FRANCIS GOELET FELLOW IN NEUROSCIENCE. DR. SI EARNED A PHD IN MOLECULAR BIOLOGY FROM THE ALBERT EINSTEIN COLLEGE OF MEDICINE. RESEARCH FOCUS: ROLE OF SYNAPTIC PROTEIN SYNTHESIS IN INFORMATION ACQUISITION AND MEMORY STORAGE. 15. PAUL TRAINOR, PHD, INVESTIGATOR, JOINED SIMR IN 2001 FROM A RESEARCH POSITION AT THE NATIONAL INSTITUTE FOR MEDICAL RESEARCH AT MILL HILL, LONDON, WHERE HE COMPLETED POSTDOCTORAL TRAINING. DR. TRAINOR HAS A PHD IN DEVELOPMENTAL BIOLOGY FROM CHILDREN'S MEDICAL RESEARCH INSTITUTE AT THE UNIVERSITY OF SYDNEY, AUSTRALIA. RESEARCH FOCUS: INVESTIGATION OF THE INTERACTIONS BETWEEN DISTINCT TISSUES IN THE BODY AND THEIR REGULATION DURING NORMAL DEVELOPMENT TO REVEAL PATHWAYS THAT REGULATE NORMAL CRANIAL AND FACIAL DEVELOPMENT. 16. JERRY WORKMAN, PHD, INVESTIGATOR, JOINED SIMR IN 2003 FROM THE PENNSYLVANIA STATE UNIVERSITY WHERE HE HELD THE PAUL BERG PROFESSORSHIP OF BIOCHEMISTRY AND WAS AN ASSOCIATE INVESTIGATOR OF THE HOWARD HUGHES MEDICAL INSTITUTE. DR. WORKMAN EARNED A PHD IN CELL AND MOLECULAR BIOLOGY FROM THE UNIVERSITY OF MICHIGAN AND COMPLETED POSTDOCTORAL TRAINING AT THE ROCKEFELLER UNIVERSITY WITH DR. BOB ROEDER. RESEARCH FOCUS: STUDY OF THE PROTEIN COMPLEXES THAT MODIFY CHROMATIN. 17. TING XIE, PHD, INVESTIGATOR, JOINED SIMR IN 2000 AFTER COMPLETING A HOWARD HUGHES MEDICAL INSTITUTE POSTDOCTORAL FELLOWSHIP IN THE LABORATORY OF DR. ALLAN C. SPRADLING AT THE CARNEGIE INSTITUTION OF WASHINGTON. DR. XIE RECEIVED HIS PHD FROM THE JOINT GRADUATE PROGRAM IN MOLECULAR BIOLOGY AND BIOCHEMISTRY OF RUTGERS UNIVERSITY AND THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY. RESEARCH FOCUS: GENETIC AND MOLECULAR ANALYSIS OF STEM CELLS AND GERM CELL DEVELOPMENT IN DROSOPHILA AND MOUSE. |
| 18. C. RON YU, PHD, INVESTIGATOR, JOINED SIMR IN 2005 FROM THE LABORATORY | OF DR. RICHARD AXEL AT COLUMBIA UNIVERSITY CENTER FOR NEUROBIOLOGY AND BEHAVIOR WHERE HE HELD A NATIONAL INSTITUTES OF HEALTH MENTORED RESEARCH SCIENTIST AWARD FROM THE NATIONAL INSTITUTE OF MENTAL HEALTH. DR. YU EARNED HIS PHD IN MOLECULAR, CELLULAR, AND BIOPHYSICAL STUDIES AT COLUMBIA UNIVERSITY. RESEARCH FOCUS: HOW OLFACTORY SENSORY INFORMATION IS DETECTED, INTEGRATED, AND PROCESSED IN THE BRAIN TO INFLUENCE SPECIFIC INNATE BEHAVIORS. 19. SARAH ZANDERS, PHD, ASSISTANT INVESTIGATOR AND VICE DEAN OF THE GRADUATE SCHOOL, JOINED SIMR IN 2016 AFTER COMPLETION OF HER POSTDOCTORAL TRAINING IN BASIC SCIENCES AT THE FRED HUTCHINSON CANCER RESEARCH CENTER (FHCRC) WITH SUPPORT FROM A PATHWAY TO INDEPENDENCE AWARD FROM THE NATIONAL INSTITUTES OF HEALTH. FHCRC FACULTY MEMBERS HARMIT S. MALIK, PHD, AND GERRY SMITH, PHD, ADVISED HER RESEARCH ON FERTILITY, GENOME EVOLUTION, AND THE ORIGIN OF NEW SPECIES. DR. ZANDERS RECEIVED HER PHD IN GENETICS AND DEVELOPMENT FROM CORNELL UNIVERSITY. RESEARCH FOCUS: THE EFFECTS OF GENETIC CONFLICTS CAUSED BY SELFISH GENES THAT ARE EMBEDDED IN EUKARYOTIC GENOMES. 20. JULIA ZEITLINGER, PHD, INVESTIGATOR, JOINED SIMR IN 2007 FROM THE LAB OF DR. RICHARD YOUNG AT THE WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH AT MASSACHUSETTS INSTITUTE OF TECHNOLOGY WHERE SHE WAS THE RECIPIENT OF A LONG-TERM POSTDOCTORAL FELLOWSHIP FROM THE HUMAN FRONTIER SCIENCE PROGRAM. DR. ZEITLINGER EARNED A PHD IN MOLECULAR BIOLOGY FROM THE EUROPEAN MOLECULAR BIOLOGY LABORATORY IN HEIDELBERG, GERMANY. RESEARCH FOCUS: ANALYSIS OF THE GENE REGULATORY NETWORKS UNDERLYING CELLULAR DIFFERENTIATION. TECHNOLOGY CENTERS 1. PAUL KULESA, PHD, DIRECTOR OF IMAGING, JOINED SIMR IN 2002 AFTER COMPLETING A BURROUGHS WELLCOME FUND POSTDOCTORAL FELLOWSHIP IN THE LABORATORY OF DR. SCOTT E. FRASER AT THE CALIFORNIA INSTITUTE OF TECHNOLOGY. DR. KULESA RECEIVED A PHD IN APPLIED MATHEMATICS UNDER DR. J.D. MURRAY AT THE UNIVERSITY OF WASHINGTON. RESEARCH FOCUS: CELL MIGRATION IN DEVELOPMENT AND CANCER. 2. MICHAEL WASHBURN, PHD, DIRECTOR OF PROTEOMICS, JOINED SIMR IN 2003 FROM THE TORREY MESA RESEARCH INSTITUTE IN SAN DIEGO WHERE HE WAS A SENIOR STAFF SCIENTIST IN PROTEOMICS. HE EARNED A PHD IN BIOCHEMISTRY AND ENVIRONMENTAL TOXICOLOGY FROM MICHIGAN STATE UNIVERSITY BEFORE COMPLETING A POSTDOCTORAL FELLOWSHIP WITH PROFESSOR JOHN YATES, III IN THE DEPARTMENT OF MOLECULAR BIOTECHNOLOGY AT THE UNIVERSITY OF WASHINGTON. RESEARCH FOCUS: QUANTITATIVE PROTEOMICS AND PROTEIN COMPLEX DYNAMICS. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (6 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| STOWERS SCIENTIFIC EDUCATION INSTITUTE | ||||||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 205916445 | SUPPORT ORG | DE | 501(C)(3) | 12A, I | SIMR | Yes (true) |
| STOWERS RESOURCE MANAGEMENTINC | ||||||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 412186719 | SUPPORT ORG | DE | 501(C)(3) | 12A, I | SIMR | Yes (true) |
| BIOMED VALLEY CORPORATION | ||||||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 743238244 | SUPPORT ORG | DE | 501(C)(3) | 12A, I | SIMR | Yes (true) |
| STOWERS REAL ESTATE HOLDING CORPORATION | ||||||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 261472230 | TITLE HOLDING | DE | 501(C)(2) | N/A | SRM | Yes (true) |
| STOWERS POLICY INSTITUTE INC | ||||||||||
| 100O EAST 50TH STREET | KANSAS CITY | MO | 64110 | 203270502 | SEE PART VII | DE | 501(C)(4) | N/A | SIMR | Yes (true) |
| THE GRADUATE SCHOOL OF SIMR | ||||||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 464588696 | EDUCATION | MO | 501(C)(3) | 2 | SIMR | Yes (true) |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BIOMED VALLEY DISCOVERIESINC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1000 EAST 50TH STREET | AddressLine1Txt |
| City | KANSAS CITY | CityNm |
| State Abbreviation | MO | StateAbbreviationCd |
| ZIP | 64110 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 061646533 | EIN |
| Primary Activities | SEE PART VII | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BVC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Entity Type | C CORP | EntityTypeTxt |
| Share Of Total Income | $0 | ShareOfTotalIncomeAmt |
| Share Of EOY Assets | $0 | ShareOfEOYAssetsAmt |
| Controlled Organization | Yes (true) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | Yes (true) | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | Yes (true) | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (true) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (10 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| BIOMED VALLEY DISCOVERIES INC | ||
| A | $755,726 | MARKET VALUE |
| BIOMED VALLEY DISCOVERIES INC | ||
| A | $15,304 | MARKET VALUE |
| STOWERS RESOURCE MANAGEMENT INC | ||
| C | $63,000,000 | MARKET VALUE |
| STOWERS REAL ESTATE HOLDING CORP | ||
| K | $2,230,551 | MARKET VALUE |
| STOWERS RESOURCE MANAGEMENT INC | ||
| P | $26,810,693 | COST REIMB. |
| THE GRADUATE SCHOOL OF SIMR | ||
| P | $1,217,267 | COST REIMB. |
| BIOMED VALLEY DISCOVERIES INC | ||
| P | $342,202 | COST REIMB. |
| BIOMED VALLEY DISCOVERIES INC | ||
| Q | $429,034 | COST REIMB. |
| THE GRADUATE SCHOOL OF SIMR | ||
| R | $1,285,700 | MARKET VALUE |
| SEE PART VII FOR ADDITIONAL INFORMATION | ||
Supplemental Information Detail SupplementalInformationDetail (12 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART II, LINE (5), COLUMN B: | STOWERS POLICY INSTITUTE INC'S. ("SPI") PRIMARY ACTIVITY IS TO PROMOTE INNOVATIVE AND ETHICAL BIOMEDICAL RESEARCH, THERAPIES AND CURES, AND TO ADVOCATE FOR A POLITICAL, ECONOMIC AND SOCIAL ENVIRONMENT THAT ADVANCES, FACILITIES, AND PROTECTS THAT RESEARCH AND THOSE THERAPIES AND CURES. |
| PART IV, LINE (1), COLUMN B: | BIOMED VALLEY DISCOVERIES, INC.'S ("BVD") PRIMARY ACTIVITY IS THE DEVELOPMENT AND MARKETING OF SCIENTIFIC DISCOVERIES. BIOMED VALLEY CORPORATION ("BVC") IS THE 100% OWNER OF BVD STOCK. |
| PART V, LINE 2 (1) BVD: | SIMR RECEIVES ROYALTY PAYMENTS FROM BVD PURSUANT TO A LICENSED TECHNOLOGY AGREEMENT DATED JANUARY 29, 2006. THESE ROYALTY PAYMENTS DO NOT CONSTITUTE GROSS INCOME DERIVED FROM AN UNRELATED TRADE OR BUSINESS UNDER SECTION 512(B)(13). THE ROYALTY PAYMENTS FROM BVD TO SIMR DO NOT REDUCE BVD'S TAXABLE INCOME, WHICH WOULD HAVE BEEN UNRELATED BUSINESS INCOME IF BVD WERE EXEMPT UNDER SECTION 501(C)(3) AND HAD THE SAME EXEMPT PURPOSE AS SIMR. IN ADDITION, THE SPECIAL RULE UNDER 512(B)(13)(E) APPLIES. |
| PART V, LINE 2 (2) BVD: | TYPE A, SIMR RECEIVES SUBLEASE PAYMENTS FROM BVD BASED ON COST FOR LESS THAN 300 SQ FT OF SPACE FOR A LIMITED USE PURPOSE. THE RENT PAYMENTS FROM BVD TO SIMR DO NOT REDUCE BVD'S TAXABLE INCOME WHICH WOULD HAVE BEEN UBTI IF BVD WERE EXEMPT UNDER 501(C)(3) AND HAD THE SAME EXEMPT PURPOSE AS SIMR. THEREFORE, NO PORTION OF THE RENT PAYMENTS FROM BVD CONSTITUTES UNRELATED BUSINESS INCOME TO SIMR UNDER SECTION 512(B)(13). |
| PART V, LINE 2 (3) SRM: | TYPE C, SRM PROVIDED FINANCIAL SUPPORT TO SIMR TO BE USED BY SIMR IN FURTHERANCE OF SIMR'S EXEMPT PURPOSE OF CONDUCTING MEDICAL RESEARCH. |
| PART V, LINE 2, (4) SREHC | TYPE K, SIMR ENTERED INTO A LEASE EFFECTIVE JANUARY 1, 2009 WITH SREHC, A 501(C)(2) TAX EXEMPT ORGANIZATION THAT IS A RELATED PARTY TO SIMR. THE LEASE HAS AN ORIGINAL TERM OF 10 YEARS WITH A PROVISION FOR ADDITIONAL OPTION YEARS FOR A 280,000 SQUARE FEET BUILDING. REFLECTS SIMR'S LEASE PAYMENTS TO SREHC IN 2019. |
| PART V, LINE 2, (5) SRM | TYPE P, SIMR REIMBURSED SRM FOR COSTS ASSOCIATED WITH SRM'S ADMINISTRATIVE AND SUPPORT SERVICES PROVIDED TO SIMR. SRM IS A SUPPORTING ORGANIZATION TO SIMR. |
| PART V, LINE 2, (6) GSSIMR | TYPE P, SIMR REIMBURSED GSSIMR FOR CERTAIN STUDENT EXPENSES INCURRED DURING TIME SPENT IN SIMR LABS. |
| PART V, LINE 2, (7) BVD | TYPE P, SIMR REIMBURSED BVD FOR SERVICES ON THE SERVICE COST METHOD. |
| PART V, LINE 2, (8) BVD | TYPE Q, BVD REIMBURSED SIMR FOR SERVICES ON THE SERVICE COST METHOD. |
| PART V, LINE 2, (9) GSSIMR | TYPE R, EACH ACADEMIC YEAR, SIMR PROVIDES GSSIMR WITH AN APPROPRIATION BASED ON A PER CAPITA FUNDING FORMULA RELATED TO THE NUMBER OF ACTIVELY ENROLLED PREDOCTORAL RESEARCHERS AT GSSIMR. |
| PART V, LINE 2, (10): | ALL OTHER TRANSACTIONS FOR LINE 1 WERE BETWEEN 501(C)(3) PUBLIC CHARITIES AND BELOW REPORTING THRESHOLDS. |
Comments